WO2006062200A1 - Nucleic acid library and protein library - Google Patents
Nucleic acid library and protein library Download PDFInfo
- Publication number
- WO2006062200A1 WO2006062200A1 PCT/JP2005/022688 JP2005022688W WO2006062200A1 WO 2006062200 A1 WO2006062200 A1 WO 2006062200A1 JP 2005022688 W JP2005022688 W JP 2005022688W WO 2006062200 A1 WO2006062200 A1 WO 2006062200A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acid
- protein
- solid support
- surface region
- library
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
- B01J2219/00513—Essentially linear supports
- B01J2219/00515—Essentially linear supports in the shape of strings
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
- B01J2219/00513—Essentially linear supports
- B01J2219/0052—Essentially linear supports in the shape of elongated tubes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00585—Parallel processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00596—Solid-phase processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00657—One-dimensional arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00722—Nucleotides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00725—Peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
Definitions
- the present invention relates to a nucleic acid library (aggregate of nucleic acids) containing a plurality of nucleic acids immobilized on the surface of a solid support, and a plurality of proteins displayed (presented) on the surface of the solid support. Containing protein libraries (aggregates of proteins).
- protein arrays protein chips
- a plurality of types of proteins are fixed in a predetermined region on the surface of the solid support, and the types of proteins can be identified by the fixing positions of the proteins.
- the protein array is useful, for example, for screening proteins that can bind to a target substance (for example, protein, DNA, etc.) from a plurality of types of proteins.
- the protein immobilized on the surface of the solid support is denatured and deactivated by drying, and the protein immobilized on the surface of the solid support is immediately denatured and deactivated. When this occurs, it is difficult to regenerate the protein, so it has been difficult to store and use it for a long time.
- the analysis can be started immediately after the protein is supplied because the analysis can be performed only after the supplied protein is fixed on the surface of the solid support.
- the protein supply power required a lot of time and effort to start the analysis. That is, protein supply and protein It was difficult to efficiently analyze proteins because it was a separate and independent technology.
- a nucleic acid library having two or more types of library sets that exist in a state of being separated from each other, wherein each library unit has an in vitro transcription'translation system or in vitro translation.
- the system comprises a nucleic acid capable of expressing one or more kinds of proteins and a protein trap provided in the vicinity of the nucleic acid.
- Each library unit is provided on the surface of a solid support, and A nucleic acid library in which nucleic acids contained in a rally unit are fixed on the surface of a solid support provided with each library unit has been developed (see Patent Document 1).
- nucleic acid library different types of library units exist in a state of being separated from each other, and protein capture bodies are provided in close proximity to the nucleic acid in each library unit.
- the distance between the nucleic acid contained in the library unit and the protein capture body is overwhelmingly larger than the distance between the nucleic acid contained in the same library unit and the protein capture body. Therefore, proteins that also express nucleic acid strength in each library unit are preferentially captured by protein catchers contained in the same library unit over protein catchers contained in different types of library units. Thus, cross-contamination of proteins expressed in different types of library units can be effectively prevented.
- nucleic acid-expressed proteins contained in each library unit are identical to the same library. It is displayed (presented) on the solid support while being captured by the protein trap contained in the unit. That is, according to the nucleic acid library, a plurality of types of proteins can be supplied at a time in a state in which they are associated with nucleic acids encoding them and displayed on a solid support. Protein analysis can be performed efficiently in parallel.
- the nucleic acid library is immediately converted into a protein library by subjecting each library unit to an in vitro transcription / translation system or an in vitro translation system.
- protein supply and protein assembly are Since they are integrated, the plurality of types of proteins can be analyzed immediately after the supply of a plurality of types of proteins.
- nucleic acid library even if the protein displayed on the solid support is denatured or inactivated, the protein can be easily expressed by re-expressing the nucleic acid corresponding to the protein. Can be played.
- Patent Document 1 International Publication WO03Z083111 Pamphlet
- Patent Document 1 in order to provide a nucleic acid and a protein capture body close to each library unit, one end of the nucleic acid is fixed to a solid support, and a protein capture body is provided at the other end of the nucleic acid. The positional relationship between the nucleic acid and the protein capturing body is associated. Thus, when the library unit is formed by associating the positional relationship between the nucleic acid and the protein trap for each library unit, the efficiency of producing the nucleic acid library is lowered.
- the present invention can supply a plurality of types of proteins at once in association with the nucleic acids that encode them, and immediately analyze the plurality of types of proteins after supplying the plurality of types of proteins. It is a nucleic acid library that can be performed in parallel and can easily regenerate proteins that have been denatured or inactivated, and it is necessary to associate the positional relationship between the nucleic acid and the protein trap in the production. It is an object of the present invention to provide a nucleic acid library that can be efficiently produced and a method for producing the same.
- Another object of the present invention is to provide a protein library prepared using the nucleic acid library of the present invention, and a method for preparing a protein library using the nucleic acid library of the present invention. .
- the present invention provides a first solid support and an in vitro transcription / translation system or in vitro translation system fixed to a predetermined surface region of the first solid support.
- Each of the plurality of nucleic acid groups is fixed to one partial region of the plurality of partial regions that are separated from each other on the predetermined surface region, and the plurality of protein capture bodies
- the second solid support is arranged with respect to the first solid support so that the predetermined surface region to which the plurality of nucleic acid groups are fixed is close to the predetermined surface region to which the plurality of nucleic acid groups are fixed.
- a nucleic acid library is provided.
- nucleic acid immobilization surface region a predetermined surface region of the second solid support (hereinafter referred to as “protein capturer fixed surface region”! Is fixed. ) Is close to a predetermined surface region (hereinafter sometimes referred to as “nucleic acid immobilization surface region”) of the first solid support in which a plurality of nucleic acid groups are immobilized in a state of being separated from each other.
- the different protein capture bodies for each nucleic acid group are close to each other, and the distance between one nucleic acid group and a protein capture body close to one nucleic acid group It is overwhelmingly smaller than the distance to the body. Since each protein capturer can capture any protein expressed from each nucleic acid group, each nucleic acid group may be in close proximity to a different protein capturer.
- the protein expressed from each nucleic acid group has priority over the protein catcher adjacent to each nucleic acid group. Therefore, cross-contamination of proteins expressed from each nucleic acid group is prevented. That is, according to the nucleic acid library of the present invention, a plurality of types of proteins can be displayed on the second solid support in a state in which they are associated with the nucleic acids that encode them, thereby analyzing a plurality of types of proteins. Can be performed efficiently in parallel.
- the nucleic acid library of the present invention is immediately converted into a protein library by subjecting it to an in vitro transcription / translation system or an in vitro translation system. That is, in the nucleic acid library of the present invention, the protein supply and the protein assembly are in the form of a body. Therefore, according to the nucleic acid library of the present invention, it is possible to analyze the plurality of types of proteins immediately after supplying the plurality of types of proteins.
- nucleic acid library of the present invention even if the protein displayed on the second solid support is denatured or inactivated, the nucleic acid group corresponding to the protein is collected. By re-expressing the protein, the protein can be easily regenerated.
- a nucleic acid fixing surface region is formed by a step of fixing a plurality of nucleic acid groups in a state of being separated from each other to a predetermined surface region of the first solid support.
- the protein capturer immobilization surface region is formed by fixing a plurality of protein capturers at a high density on the predetermined surface region of the solid support 2 so that the protein capturer immobilization surface region is close to the nucleic acid immobilization surface region.
- the second solid support may be disposed with respect to the first solid support. That is, the protein traps need not be arranged in association with the positions of the nucleic acid groups, and may be arranged randomly regardless of the positions of the nucleic acid groups. Therefore, the nucleic acid library of the present invention can be produced efficiently.
- the protein capture body is overwhelmed by the distance between adjacent protein capture bodies than the distance between adjacent partial areas among a plurality of partial areas that are separated from each other.
- the second solid support is fixed to a predetermined surface area of the second solid support with such a density that the distance between the nucleic acid fixation surface area and the protein capturer fixation surface area is separated from each other. It arrange
- the distance between adjacent partial areas among a plurality of partial areas that are separated from each other is not particularly limited, but is usually not less than 0. Olmm, preferably not less than 0.1 mm, more preferably lmm. That's it.
- the upper limit value of the distance between the adjacent partial regions is not particularly limited, and can be appropriately adjusted according to the size of the predetermined surface region of the first solid support, but is usually 10 mm.
- the “distance between partial areas” means the distance between the two closest points in the periphery of the two partial areas.
- the protein capture body has a density such that the distance between adjacent protein capture bodies is 1/100 or less of the distance between adjacent partial areas among a plurality of partial areas that are separated from each other.
- the second solid support is preferably fixed to a predetermined surface region.
- the distance between adjacent protein traps is the distance between multiple partial regions that are separated from each other. 1/100, 1 / 10,000, 1 / 10,000 or less, 1 / 100,000, 1 / 1,000,000 or less, 1 / 10,000,000 or less. The better.
- the second solid support is such that the distance between the protein capturer-immobilized surface region and the nucleic acid-immobilized surface region is 5 minutes of the distance between adjacent partial regions among a plurality of partial regions that are separated from each other. It is preferable that it is arranged with respect to the first solid support so that it is 1 or less.
- the distance between the surface area for immobilizing the protein capturer and the surface area for immobilizing the nucleic acid is 1/5 or less, 50 minutes or less, and 500 minutes or less of the distance between adjacent partial areas that are separated from each other. The smaller it is, the better it is.
- the lower limit of the distance between the protein capturer fixed surface region and the nucleic acid fixed surface region is zero.
- the shape of the first and second solid supports, the arrangement of the second solid support relative to the first solid support, and the like are as follows.
- the region is not particularly limited as long as the region can be brought close to the nucleic acid immobilization surface region, but in a preferred embodiment of the nucleic acid library of the present invention, the second solid support is made of a flexible long member.
- the second solid support is spirally mounted on the first solid support (this embodiment is hereinafter referred to as “first embodiment”).
- the sequence density of the protein capture body relative to the nucleic acid-fixed surface region can be adjusted, and expression from each nucleic acid group can be achieved. Cross contamination of the produced protein can be effectively prevented.
- the density of the protein traps on the nucleic acid-fixed surface region is larger than the density of the protein traps on the surface of the second solid support.
- the second solid support interposed between adjacent nucleic acid groups serves as a barrier, and effectively prevents cross-contamination of proteins expressed by each nucleic acid force. can do.
- the shape of the flexible long member is not particularly limited as long as it is long, and examples thereof include a thread shape, a string shape, and a tape shape.
- the shape of the first solid support is not particularly limited as long as the flexible long member can be equipped. For example, a flat plate shape, a cylindrical shape, a cylindrical shape, a prismatic shape , Rectangular tube shape, rod shape, thread shape, string shape, tape shape and the like.
- the number of windings of the second solid support is not particularly limited as long as the protein-immobilized surface region is close to each nucleic acid group.
- the number of turns of the second solid support per unit length in the winding axis direction is preferably when the shortest length is the unit length in the winding axis direction. Is at least once, more preferably at least twice.
- the upper limit value of the number of turns of the second solid support per unit length in the winding axis direction is not particularly limited and can be appropriately adjusted according to the width of the second solid support.
- the length of each partial region in the winding axis direction is not particularly limited, but is usually 0.05 mm or more, preferably 2 mm or more.
- the upper limit of the length in the winding axis direction of each partial region is not particularly limited, and is a force that can be appropriately adjusted according to the size of the first solid support and the like, which is usually 10 mm.
- the width of the second solid support is less than or equal to the unit length in the winding axis direction, and the second solid support is mounted on the first solid support so that different regions of the protein immobilization surface region do not overlap each other. It is preferable to do.
- the “winding shaft” means a line passing through the center of the spiral formed by the second solid support mounted on the first solid support.
- the protein displayed on the second solid support is analyzed while the second solid support is arranged with respect to the first solid support.
- the second solid support may become an obstacle to protein analysis. is there.
- the second solid support remains in a state in which the second solid support is arranged with respect to the first solid support. Access to the protein displayed on the support is difficult. In such a case, it is difficult to automate a series of operations up to protein analysis using the protein library alone as a protein library production ability.
- the second solid support when the entire nucleic acid immobilization surface region is covered with the second solid support, for example, the second solid support has a hollow part.
- Material for example, a flexible sheet-like member curved or bent into a cylindrical shape, a rectangular tube shape, a ⁇ c '' shape, a ⁇ U '' shape, etc.
- the first solid support is the second The case where it is accommodated in the hollow part of a solid support is mentioned.
- the second solid support is displayed on the second solid support even when the second solid support remains arranged with respect to the first solid support. Easy access to proteins. Therefore, according to the first aspect, it is possible to easily automate a series of operations up to protein analysis using a protein library.
- the method for identifying the type of nucleic acid immobilized on the surface of the first solid support is not particularly limited, but in a preferred embodiment of the nucleic acid library of the present invention, The position of each nucleic acid group on the surface of the first solid support is associated with the type of nucleic acid contained in each nucleic acid group (this embodiment is hereinafter referred to as “second embodiment”).
- the type of nucleic acid contained in each nucleic acid group and the type of protein expressed from each nucleic acid group can be easily identified based on the position of each nucleic acid group.
- the protein expressed from each nucleic acid group is captured by a protein capture body close to each nucleic acid group, the type of protein captured by the protein capture body is at the position of the nucleic acid group close to the protein capture body. Based on this, it can be easily identified.
- the type of the protein capture body is not particularly limited as long as any protein expressed from each nucleic acid group can be captured, but in a preferred embodiment of the present invention,
- the protein expressed from each nucleic acid group is a fusion protein of a target protein of a different type between the nucleic acid groups and a tag protein of the same type between the nucleic acid groups, and binds to each protein capture force tag protein (This mode is hereinafter referred to as “third mode”).
- the binding between the protein expressed from each nucleic acid group and the protein trap is ensured.
- the “target protein” means a protein to be analyzed that is displayed on the second solid support.
- the fusion proteins expressed from each nucleic acid group have the same orientation. U, preferred to bind with protein traps. By making the direction of the fusion protein expressed from each nucleic acid group the same, the reactivity of the fusion protein displayed on the second solid support can be made uniform and optimized.
- the present invention is a method for producing the nucleic acid library of the present invention, wherein each of the plurality of nucleic acid groups in each of the plurality of site regions of the predetermined surface region of the first solid support is provided.
- a step of fixing one of the nucleic acid groups a step of fixing the plurality of protein capturing bodies at a high density to a predetermined surface region of the second solid support, and the plurality of protein capturing bodies being fixed.
- a method comprising the step of arranging the second solid support relative to the first solid support so that the predetermined surface area is close to the predetermined surface area to which the plurality of nucleic acid groups are fixed. provide.
- the nucleic acid-immobilized surface region and the protein capturer-immobilized surface region are separately formed on the first solid support and the second solid support, respectively.
- the nucleic acid library of the present invention can be prepared by arranging the second solid support relative to the first solid support so as to be close to the nucleic acid immobilization surface region. That is, in producing the nucleic acid library of the present invention, the protein capture bodies need not be arranged in association with the positions of the nucleic acids, but may be arranged at random regardless of the positions of the nucleic acids. Therefore, according to the nucleic acid library of the present invention, the nucleic acid library of the present invention can be efficiently produced.
- the present invention provides a protein obtained by subjecting the nucleic acid library of the present invention to an in vitro transcription / translation system or an in vitro translation system to express a plurality of nucleic acid groups contained in the nucleic acid library at once. Provide a library.
- nucleic acid library of the present invention Even if the nucleic acid library of the present invention is subjected to an in vitro transcription / translation system or an in vitro translation system all at once, cross-contamination of proteins in which each nucleic acid group force is expressed is prevented. Are displayed at once on a second solid support in association with the nucleic acid encoding them. Therefore, according to the protein library of the present invention, it is possible to efficiently analyze a plurality of types of proteins in parallel.
- the protein library of the present invention is immediately prepared by expressing the nucleic acid group contained in the nucleic acid library of the present invention. Thereafter, the plurality of types of proteins can be analyzed immediately.
- the protein library of the present invention even if the protein displayed on the solid support is denatured or inactivated, the protein group is expressed by re-expressing the nucleic acid group corresponding to the protein. Can be reproduced easily.
- the protein library of the present invention is stored in the state of a nucleic acid library, and can be repeatedly used over a long period of time by regenerating the protein library when necessary.
- the present invention provides a protein comprising the step of subjecting the nucleic acid library of the present invention to an in vitro transcription / translation system or in vitro translation system to express a plurality of nucleic acid groups contained in the nucleic acid library at one time.
- a method for producing a library is provided.
- the protein library of the present invention can be produced in a state in which cross-contamination of the protein expressed from each nucleic acid group is prevented.
- the present invention relates to a solid support and different types of proteins immobilized in a predetermined surface region of the solid support in a state of being separated from each other in an in vitro transcription'translation system or an in vitro translation system.
- a method for producing a nucleic acid library comprising a plurality of nucleic acid groups to be expressed and a protein trap fixed to the predetermined surface region in the vicinity of each nucleic acid group, wherein the nucleic acid library is formed on the entire predetermined surface region.
- a method comprising the step of immobilizing one nucleic acid group among the plurality of nucleic acid groups is provided.
- nucleic acid and the protein capturing body are immobilized on the surface of the same solid support, it is not necessary to arrange the protein capturing body in association with the position of the nucleic acid. If the sequences are randomly arranged, the nucleic acid library can be efficiently produced.
- the order of immobilization of the nucleic acid and the protein catcher to the predetermined surface region of the solid support is not particularly limited, and the nucleic acid may be immobilized after immobilizing the protein capturer. And you can fix the protein trap after fixing the nucleic acid.
- a plurality of protein capture bodies are separated by 100 minutes of the distance between adjacent partial areas of the plurality of partial areas. It is preferable to fix at a density such that it is 1 or less. Thereby, cross-contamination of proteins expressed by each nucleic acid group force can be effectively prevented.
- the distance between adjacent protein capture bodies is less than 1/100, less than 1/1000, less than 1 / 10,000, and 100,000 minutes Less than 1 / 1,000,000 / 1,000,000 / 1,000,000 or less
- the solid support is preferably porous. Since the fluidity of the liquid (for example, in vitro transcription, translation system or in vitro translation system) is low in the pores of the solid support, the group of nucleic acids immobilized on the internal surface of the pores of the solid support is expressed. Tungsten is not easily released from the pores. Therefore, the protein expressed from the nucleic acid group can be surely captured by the protein trap, and cross-contamination of the protein in which each nucleic acid group force is expressed can be effectively prevented.
- the fluidity of the liquid for example, in vitro transcription, translation system or in vitro translation system
- a plurality of types of proteins can be supplied at once in association with the nucleic acids that encode them, and the plurality of types of proteins are analyzed immediately after the supply of the plurality of types of proteins.
- a nucleic acid library that can easily regenerate proteins that have undergone denaturation or inactivation, and associates the positional relationship between the nucleic acid and the protein trap during the production.
- Nucleic acid libraries that can be efficiently produced without need are provided.
- a protein library prepared using the nucleic acid library of the present invention there is provided.
- a method for producing a protein library using the nucleic acid library of the present invention is provided.
- FIG. 1 is a perspective view of a nucleic acid library according to one embodiment of the present invention.
- FIG. 2 is a schematic diagram of the structures of various cage DNAs.
- FIG. 3 (a) shows the protein immobilized on the composite yarn using anti-His antibody and anti-GFP antibody. It is a figure which shows the detected result, (b) is a schematic diagram of a composite yarn.
- FIG. 4 shows the protein immobilized on the composite yarn with anti-His antibody, anti-GFP antibody and anti-GST.
- (b) is a schematic diagram of a composite yarn.
- FIG. 5 is a diagram showing the results of detecting proteins immobilized on cotton yarn using Cy5-labeled anti-rabbit IgG (H + L) antibody and AF488-labeled anti-murine IgG (H + L) antibody.
- FIG. 6 (a) is a schematic diagram of a cotton yarn in which nickel chelate and cage DNA are immobilized, and (b) shows the result of detecting the protein immobilized on the cotton yarn using a fluorescently labeled antibody. It is a figure.
- FIG. 7 is a schematic diagram of the structure of various cage DNAs.
- FIG. 8 (a) is a diagram showing the detection results of GST protein for binding to dartathione, (b) is a diagram showing the results of detection of alkaline phosphatase activity, and (c) is a detection of the anti- ⁇ galactosidase ScFv antibody activity. It is a figure which shows a result.
- FIG. 9 is a diagram showing the results of detecting the protein immobilized on a cellulose membrane using an antibody.
- the nucleic acid library 1 includes a first solid support 2 and a plurality of nuclei fixed to a predetermined surface region of the first solid support 2 in a state of being separated from each other.
- the solid support 2 has a cylindrical shape, but the solid support 2 has a shape of
- the solid support 4 is not limited to a columnar shape as long as it can be fitted, for example, a flat plate shape, a cylindrical shape, a prismatic shape, a rectangular tube shape, a rod shape, a string shape, a thread shape, a tape shape, etc. It may be in shape.
- the solid support 4 has a thread-like or string-like force.
- the solid support 4 is not limited to a thread-like or string-like shape as long as it is long, for example, It may be in the form of a tape.
- the thickness (diameter) of the solid support 4 is usually 0.05 to 2 mm, preferably 0.2 to lmm.
- the material constituting the solid support 2 is not particularly limited as long as it is insoluble in the liquid to which the nucleic acid library 1 is provided (for example, in vitro transcription / translation system or in vitro translation system solution). It is not something. Further, the material constituting the solid support 4 is not particularly limited as long as it is insoluble in the liquid to which the nucleic acid library 1 is provided and can give the solid support 4 flexibility.
- the material constituting the solid support 2 may be a material that can impart flexibility to the solid support 2 or a material that cannot be imparted!
- Examples of the material constituting the solid support 2 or 4 include glass; silicone; ceramics; polystyrene-based resin such as polystyrene; (meth) acrylic resin such as polymethylmetatalate; nylon 6, Polyamides such as nylon 66, polyesters such as polyethylene terephthalate, synthetic resins such as polycarbonate; polysaccharides such as agarose, dextran, and cellulose; proteins such as gelatin, collagen, and casein.
- the materials can be used alone or in combination of two or more materials.
- the solid support 2 or 4 may be either porous or nonporous, but is preferably porous.
- the porous solid support include those obtained by treating the surface of a solid support made of a synthetic resin such as nylon with an acid such as hydrochloric acid, and an aggregate of fibers (for example, a twisted fiber). It is done.
- the surface area of the solid support 2 or 4 increases, so that more nucleic acid groups 3 or protein capture bodies 5 can be immobilized on the surface.
- each of the plurality of nucleic acid groups 3 includes a plurality of portions. It is fixed to one of the areas.
- the plurality of nucleic acid groups 3 of the solid support 2 Fixed to a predetermined surface area in a state of being separated from each other.
- the surface of the solid support 2 is infiltrated with the liquid in addition to the outer surface (external surface) of the solid support 2 as long as it comes into contact with the liquid (for example, in vitro transcription'translation system or solution of in vitro translation system).
- the inner surface (inner surface) of the solid support 2 (for example, the inner surface of the pores of the solid support 2) is also included.
- the distance between adjacent partial regions among the plurality of partial regions that are separated from each other is usually 0.01 mm or more, preferably 0.1 mm or more, and more preferably 1 mm or more.
- the upper limit of the distance between adjacent partial regions among a plurality of partial regions that are separated from each other is not particularly limited, depending on the area of the predetermined surface region to which a plurality of nucleic acid groups 3 are fixed.
- the force that can be adjusted appropriately is usually 10mm.
- Each nucleic acid group 3 expresses different types of proteins in an in vitro transcription / translation system or in vitro translation system.
- a protein expressed from one nucleic acid group 3 (at least one protein when two or more proteins are expressed from one nucleic acid group 3) is not expressed from another nucleic acid group 3. It can be said that one nucleic acid group 3 and another nucleic acid group 3 express different types of proteins. If a protein expressed from one nucleic acid group 3 is not expressed from another nucleic acid group 3, there may be a problem of cross-contamination of proteins expressed from each nucleic acid group 3. This problem has been resolved.
- nucleic acid group that expresses only the same type of protein as one nucleic acid group 3 is fixed to the predetermined surface region of the solid support 2 It may be.
- a nucleic acid group that expresses only the same type of protein as one nucleic acid group 3 may be fixed to a predetermined surface region of the solid support 2 in the vicinity of the one nucleic acid group 3, or one nucleic acid group 3 It may be fixed to a predetermined surface region of the solid support 2 in a separated state.
- Each nucleic acid group 3 expresses a plurality of nucleic acids that express only the same type of protein and / or different types of proteins so that one or more types of proteins are expressed from each nucleic acid group 3.
- a plurality of nucleic acids expressing only the same type of protein may have either the same structure or different structures. Different structure For example, a force transcription control region or translation control region having the same open reading frame may have a different structure.
- each nucleic acid group 3 usually includes a plurality of nucleic acids that express only the same type of protein, but a plurality of nucleic acids that express different types of proteins. Nucleic acids may be included. For example, when a protein expressed from a certain nucleic acid group 3 is composed of a plurality of different subunits, the nucleic acid group 3 includes a plurality of nucleic acids that express each subunit.
- the protein that each nucleic acid group 3 expresses in an in vitro transcription'translation system or in vitro translation system is a fusion protein of a target protein and a tag protein.
- the target protein is displayed on the solid support 4 and is the protein to be analyzed.
- the type of the target protein differs between the nucleic acid groups 3.
- the tag protein is, for example, a piotin-binding protein such as avidin or streptavidin, a maltose-binding protein, a polyhistidine peptide, a glutathione S-transferase, a calmodulin, an ATP-binding protein, or a receptor protein.
- the type is the same among nucleic acid groups 3.
- the nucleic acid group that expresses a protein in an in vitro transcription / translation system includes DNA and Z or RNA, and the nucleic acid group that expresses a protein in an in vitro translation system includes RNA.
- the in vitro transcription / translation system includes an in vitro transcription system capable of performing transcription from DNA to mRNA in vitro, and an in vitro translation system capable of performing translation from mRNA to protein in vitro.
- the in vitro transcription / translation system contains all the elements necessary for transcription and translation (eg, RNA polymerase, ribosome, tRNA, etc.).
- Examples of in vitro transcription / translation systems include cell-free transcription / translation systems prepared from eukaryotic and prokaryotic cell extracts.
- Examples of cell-free transcription / translation systems include E. coli (for example, Examples include cell-free transcription / translation systems prepared from cell extracts such as E.
- each nucleic acid group 3 is the same in the in vitro transcription / translation system or in vitro translation system, and the target protein is different in the nucleic acid group 3 and the same in the nucleic acid group 3. It is not particularly limited as long as a fusion protein with the tag protein can be expressed.
- nucleic acids that express a target protein in an in vitro transcription / translation system include a transcriptional regulatory region, a translational regulatory region, an open reading frame (ORF) encoding the target protein, and an open reading frame.
- DNA comprising the stop codon provided on the 3 'side of Examples of nucleic acids that express a target protein in an in vitro translation system are the same except for DNA that expresses the target protein in an in vitro transcription / translation system and thymine (T) force uracil (U). And RNA having a structure. However, in the case of RNA, a transcriptional regulatory region is not necessary.
- the transcriptional regulatory region and the translational regulatory region are not particularly limited as long as transcription from DNA to mRNA and translation from mRNA to protein are possible.
- transcriptional regulatory regions include promoters, Terminator 1, Enno, Nsa, etc.
- translation regulatory regions include Kozak sequence, Shine * Dalgarno (SD) sequence, etc.
- SD Shine * Dalgarno
- Types of in vitro transcription systems, in vitro translation systems It can be selected appropriately according to the type.
- the transcriptional regulatory region and the translational regulatory region may exist as separate regions !, or may overlap and exist! /.
- An open reading frame (ORF) encoding a protein of interest includes an open reading frame encoding a target protein and an open reading frame encoding a tag protein linked to each other.
- each nucleic acid group 3 includes, for example, a promoter and an SD sequence on the 5 'side of the open reading frame, and a stop codon on the 3' side of the open reading frame. Examples include a structure having a terminator.
- each nucleic acid group 3 may be double-stranded or single-stranded, and may be immobilized on the surface of the solid support 2 in a shifted state.
- the nucleic acid is DNA
- double-stranded In this state it is preferably fixed to the surface of the solid support 2. This is because transcription of DNA by polymerase is efficiently performed using double-stranded DNA as a substrate.
- each nucleic acid group 3 no matter what part of the nucleic acid is immobilized on the surface of the solid support 2 However, it is preferable that the 3 ′ end or 5 ′ end of the nucleic acid is fixed to the surface of the solid support 2. When the 3 ′ end or 5 ′ end of the nucleic acid is immobilized on the surface of the solid support 2, the protein can be efficiently expressed with the nuclear acidity.
- each nucleic acid group 3 is associated with the type of nucleic acid contained in each nucleic acid group 3, and the type of nucleic acid contained in each nucleic acid group 3 and the type of protein expressed from each nucleic acid group 3. Can be identified based on the position of each nucleic acid group 3.
- a plurality of protein capture bodies 5 are fixed at a high density in a predetermined surface region of the solid support 4.
- the surface of the solid support 4 is infiltrated with the liquid in addition to the outer surface (external surface) of the solid support 4 as long as it comes into contact with the liquid (for example, in vitro transcription'translation system or in vitro translation system solution).
- the inner surface (inner surface) of the solid support 4 (for example, the inner surface of the pores of the solid support 4) is also included.
- the protein trap 5 can bind to a tag protein contained in the fusion protein expressed from each nucleic acid group 3.
- tag protein Z protein traps include metal ions such as avidin, streptavidin, etc., Piotin-binding protein Z-Piotin, maltose-binding protein Z-maltose, polyhistidine peptide Z nickel-cobalt, glutathione s-transferase Z Glutathione, calmodulin Z calmodulin binding peptide, ATP binding protein ZATP, receptor protein Z ligand and the like. Since the fusion protein expressed from each nucleic acid group 3 includes tag proteins of the same type between the nucleic acid groups 3, the protein trap 5 is expressed from each nucleic acid group 3 through binding to the tag protein. It is possible to capture a few fusion proteins.
- a positively charged body or a negatively charged body may be used as the protein trap 5. Protein negatively charged at higher pH isoelectric point, since positively charged at low P H than the isoelectric point, by using a positive charge, or negatively charged body as protein capture body 5, the protein capturing The prey 5 can capture any fusion protein expressed from each nucleic acid group 3 via electrical coupling (electrostatic interaction).
- a positively charged group for example, an amino group, guazyl
- a substance having a negatively charged group for example, a carboxyl group, a sulfonyl group, or a phosphate group
- a substance having a hydrophobic group such as an alkyl group or a derivative group thereof, a phenyl group or a derivative group thereof may be used.
- the protein capturing body 5 can also capture a misaligned fusion protein expressed from each nucleic acid group 3 through a hydrophobic interaction. Can do.
- the protein expressed from each nucleic acid group 3 is a fusion of the target protein and the tag protein. Regardless of whether it is a protein or not, the protein capture body 5 is expressed from each nucleic acid group 3 and can also capture a misaligned protein. Therefore, the protein expressed from each nucleic acid group 3 is, for example, a tag It may be a target protein that is not fused with a protein, a target protein that is fused with a protein other than a tag protein, or the like.
- the protein capture body 5 has a density such that the distance between adjacent protein capture bodies is much smaller than the distance between adjacent partial areas among a plurality of partial areas that are separated from each other.
- the solid support 4 is fixed to a predetermined surface area.
- the distance between adjacent protein catchers is a density that is not more than 1/100 of the distance between adjacent partial areas among a plurality of partial areas that are separated from each other. It is preferably fixed to the surface region.
- the distance between adjacent protein capture bodies is less than 1/100, less than 1/1000, less than 1 / 10,000, and less than 100,000 minutes of the distance between adjacent partial areas among multiple partial areas that are separated from each other. 1 / less, 1 / 1,000,000 or less, 1 / 1,000,000 or less! /, The smaller, the better.
- the solid support 4 is spirally mounted on the solid support 2!
- the solid support 4 includes a predetermined surface region (nucleic acid fixation surface region) of the solid support 2 to which a plurality of nucleic acid groups 3 are fixed and a predetermined support of the solid support 4 to which a plurality of protein capture bodies 5 are fixed.
- the solid support so that the distance to the surface area (surface area on which the protein capturer is fixed) is overwhelmingly smaller than the distance between adjacent partial areas among a plurality of partial areas that are separated from each other. 2 are outfitted.
- the distance between the nucleic acid immobilization surface area and the protein capturer immobilization surface area is the distance between the adjacent partial areas of the plurality of partial areas that are separated from each other. It is preferable to be less than one fifth of the distance between the zones.
- the distance between the nucleic acid-immobilized surface region and the protein catcher-immobilized surface region is less than one fifth, less than one-fifth, and less than one-fifth of the distance between adjacent partial regions among a plurality of partial regions that are separated from each other The smaller it is, such as 1 / min or 1/5000 min or less, the better. Note that the lower limit of the distance between the protein capturer fixed surface region and the nucleic acid fixed surface region is zero.
- the number of windings of the solid support 4 per unit length in the winding axis direction is not particularly limited as long as the protein capturer fixing surface region is close to each nucleic acid group 3, but the winding of a plurality of partial regions is not limited.
- the number of windings of the solid support 4 per unit length in the winding axis direction is preferably 1 mm or more, more preferably 2 times Zmm or more.
- the upper limit value of the number of turns of the solid support 4 per unit length in the winding axis direction is not particularly limited and can be appropriately adjusted according to the width of the solid support 4.
- the length of each partial region in the winding axis direction is not particularly limited, but is usually 0.05 mm or more, preferably 2 mm or more.
- the upper limit value of the length of each partial region in the winding axis direction is not particularly limited, and is a force that can be appropriately adjusted according to the size of the first solid support and the like, which is usually 10 mm.
- the width of the solid support 4 is equal to or less than the unit length in the winding axis direction, and the solid support 4 is mounted on the first solid support so that different regions of the protein-immobilized surface region do not overlap each other.
- the “winding axis” means a line passing through the center of a spiral formed by the solid support 4 mounted on the solid support 2.
- the number of windings of the solid support 4 per winding axis direction unit length is 1 If it is Zmm or more, a different region of the protein trap body fixing surface region is close to each nucleic acid group 3, so that cross-contamination of proteins expressed from each nucleic acid group 3 can be effectively prevented. .
- the protein capturing bodies 5 are arranged at high density close to the predetermined surface region of the solid support 2 to which the nucleic acid groups 3 are fixed. Different protein capture bodies 5 are close to each other in each of the nuclear acid groups 3. Further, since each nucleic acid group 3 is fixed to the surface of the solid support 2 in a state of being separated from each other, the distance between one nucleic acid group 3 and the protein capture body 5 adjacent to one nucleic acid group 3 is different from the other. In close proximity to one nucleic acid group 3 and one nucleic acid group 3 It is overwhelmingly smaller than the distance to the protein capture body 5 to be.
- the nucleic acid library 1 is subjected to an in vitro transcription / translation system or an in vitro translation system and a plurality of nucleic acid groups 3 contained in the nucleic acid library are expressed at once, the proteins expressed from each nucleic acid group 3 are expressed. Is preferentially captured by the protein capturing body 5 adjacent to each nucleic acid group 3, so that cross-contamination of the protein expressed from each nucleic acid group 3 is prevented. Particularly in the nucleic acid library 1, the solid support 4 interposed between the nucleic acid groups 3 serves as a barrier, and cross-contamination of proteins expressed from the nucleic acid groups 3 is effectively prevented.
- nucleic acid library 1 by subjecting the nucleic acid library 1 to an in vitro transcription / translation system or an in vitro translation system to express a plurality of nucleic acid groups 3 contained in the nucleic acid library 1 at a time, A protein library in which a plurality of types of expressed proteins are displayed on the solid support 4 in a state in which they are associated with the nucleic acid encoding them can be prepared.
- a protein library in which a plurality of types of expressed proteins are displayed on the solid support 4 in a state in which they are associated with the nucleic acid encoding them can be prepared.
- all of the nucleic acid groups 3 included in the nucleic acid library 1 may be used, or some of the nucleic acid groups 3 included in the nucleic acid library 1 may be included. May be.
- Nucleic acid library 1 is immediately converted into a protein library when subjected to an in vitro transcription / translation system or in vitro translation system, so the protein supply and protein assembly system are integrated.
- the analysis of the plurality of types of proteins can be started immediately after the supply of the plurality of types of proteins.
- the protein displayed on the solid support 4 can be accessed even when the solid support 4 is mounted on the solid support 2. Since it is easy, it is possible to easily automate a series of operations up to protein analysis using a protein library.
- the nucleic acid encoding the protein is expressed again.
- the protein can be regenerated.
- the nucleic acid library 1 is maintained until the next use. It can be used repeatedly over a long period of time by regenerating the protein library when necessary.
- the nucleic acid library 1 is obtained by fixing one nucleic acid group of a plurality of nucleic acid groups 3 to a plurality of site regions that are separated from each other in a predetermined surface region of the solid support 2, and A plurality of protein capture bodies 5 are fixed at a high density to a predetermined surface area of the support 4, and a predetermined surface area where a plurality of protein capture bodies 5 are fixed is a predetermined surface area where a plurality of nucleic acid groups 3 are fixed.
- the solid support 4 can be manufactured by mounting the solid support 4 on the solid support 2 so as to be close to the substrate.
- the method for immobilizing a nucleic acid or protein trap on the surface of a solid support is not particularly limited.
- specific interactions between specific substances for example, covalent bonds (for example, amide bonds, disulfide bonds, thioethers). (Bond) formation or the like can be used.
- Specific interactions between specific substances include, for example, avidin or a derivative thereof (eg, streptavidin, extraavidin, NeutrAvidin) Z piotin or a derivative thereof (eg, iminobiotin) Maltose binding protein Z maltose; metal ions such as polyhistidine peptide nickel and cobalt; glutathione S transferase Z glutathione; calmodulin Z calmodulin binding peptide; ATP binding protein ZATP; nucleic acid Z complementary nucleic acid; Specific interactions such as body protein Z ligand; enzyme Z substrate; antibody Z antigen; IgGZ protein A or G can be used. Substances that produce specific interactions can be bound to nucleic acids, protein capture bodies or solid supports according to conventional methods.
- the covalent bond includes a functional group (including a functional group artificially introduced into the nucleic acid or protein capture body) of the nucleic acid or protein capture body 5 included in the nucleic acid group 3, and the solid support 2 or Can be formed by reacting with a functional group possessed by 4 (including a functional group artificially introduced into the solid support 2 or 4).
- the functional group that forms a covalent bond include a carboxyl group, an amino group, a hydroxyl group, a sulfhydryl group, and an aldehyde group.
- a crosslinking agent can be used for the formation of the covalent bond.
- cross-linking agents include N —Succinimidyl (4—iodoacetyl) aminobenzoate (SIAB), dimaleimide, dithio-bis-nitrobenzoic acid (DTNB), N- N-succinimidyl-S-acetyl-thioacetate (SATA), N-succinimidyl-3- (2-pyridyldithio) propionate ) (SPDP), succinimidyl 4- (N-maleimidomethyl) cyclohexane-1-carboxylate (SMCC), 6-hydrazinonicotimide And polyfunctional reagents such as (6-hydrazinonicotimide) (HYNIC), m-maleimidobenzoyl-N-hydroxysuccinimide ester (MB), and the like.
- MIB N —Succinimidyl (4—iodoacetyl) aminobenzoate
- nucleic acid solutions spotted in the adjacent site regions are preferable to spot in advance.
- a solution containing a substance that can be used By pre-spotting such a solution, a barrier is formed inside the solid support 2 and it is possible to prevent contamination from occurring between the nucleic acid solutions spotted in the adjacent site regions.
- substances that can prevent the passage of nucleic acids include protein substances such as casein, skim milk, gelatin, and BSA, sugars such as glucose, sucrose, raffinose, dextrin, and starch, dextran sulfate, PVP, glycerin, Examples include viscous substances such as PEG and substances A released from the solid support 2.
- proteinaceous substances such as casein, skim milk, gelatin, BSA, and fusion proteins expressed from each nucleic acid group 3 are included.
- the tamper expressed from each nucleic acid group 3 It is possible to prevent the soil from adsorbing to the solid support 2 nonspecifically.
- the predetermined surface area of the solid support 2 to which the protein capturing body 5 is fixed is changed to the predetermined surface area of the solid support 4 to which the nucleic acid group 3 is fixed. What is necessary is just to make it adjoin to a predetermined surface area
- Example 1 a composite yarn composed of a cage DNA-immobilized nylon yarn and a nickel chelate-immobilized cotton yarn wound around the nylon yarn was subjected to an in vitro transcription / translation system and expressed from the cage DNA.
- a His-tagged protein was immobilized on a nickel chelate immobilized cotton thread.
- the distance between adjacent nickel chelates is expected to be about 2 to 20 nm (estimated value).
- the distance between adjacent saddle DNA groups is about 5 mm, so the distance between adjacent nickel chelates is adjacent.
- the distance between adjacent DNA groups is 1 / 2.5 million (about 0.000004 times), and the distance between adjacent nickel chelates is far smaller than the distance between adjacent DNA groups. .
- His tag (tag protein consisting of 6 histidines) at the 5 'end of the streptavidin gene
- the coding sequence is ligated, and the T7 promoter sequence and ribosome binding sequence (RBS) are attached to the 5 'end, and the T7 sequence is attached to the 3' end.
- RBS ribosome binding sequence
- GFP green fluorescent protein
- His-encoded DNA hereinafter “GFP-His-type D”.
- NA ". ) was prepared using the Rapid Translation System (Roche) control plasmid pIVEX control vector GFP (see SEQ ID NO: 4).
- This plasmid has a structure expressing a protein in which a His tag is fused to the C-terminal side of GFP.
- NA ". ) was prepared by fusing the His tag coding sequence to the 3 'end of the GST gene using a Roche Linear template generation set, His-tag (see SEQ ID NO: 5).
- Figure 2 shows a schematic diagram of the structure of each cage DNA.
- the composition and reaction conditions of the PCR reaction solution are as follows: The The composition of the PCR reaction solution is 10 ng / ⁇ 1 DNA 4.0 ⁇ ⁇ , 20 ⁇ ⁇ forward primer (DIG-17f, see SEQ ID NO: 1) 8.0 ⁇ 20 ⁇ ⁇ reverse primer (see l lr, SEQ ID NO: 2) 8.0 1, 10 X Ex Taq buffer 20 ⁇ 1, 2.5 mM dNTPs 20 ⁇ 1, LA Taq (5U / ⁇ 1) 2.0 1, dH O 138 1 (DIG-17f, see SEQ ID NO: 1) 8.0 ⁇ 20 ⁇ ⁇ reverse primer (see l lr, SEQ ID NO: 2) 8.0 1, 10 X Ex Taq buffer 20 ⁇ 1, 2.5 mM dNTPs 20 ⁇ 1, LA Taq (5U / ⁇ 1) 2.0 1, dH O 138 1 (DIG-17f, see SEQ ID NO: 1) 8.0 ⁇ 20 ⁇ ⁇ reverse primer (see l lr, SEQ ID NO: 2)
- the total amount is 200 ⁇ 1).
- the reaction conditions were (0 94 ° C for 1 minute, (ii) 94 ° C for 1 minute, 94 ° C for 30 seconds, 55 ° C for 30 seconds and 72 ° C for 1 minute for 30 cycles. Yes, PCR products were stored at 4 ° C until use.
- the surface was treated with 4-6N hydrochloric acid (20-25 ° C, 0.5-15 seconds) and the surface was made porous.
- 200 g / ml anti-DIG antibody (Roche) 0.41 was spotted on nylon thread at intervals of 5 mm and dried at room temperature for 40 minutes. On the spotted antibody, 0.41 spot of purified DIG-labeled vertical DNA was spotted and dried at room temperature for 90 minutes.
- a cotton yarn with a nickel chelate fixed at a high density on the surface was wrapped around a nylon yarn with a hook-shaped DNA fixed on the surface to produce a composite yarn.
- the diameter of the cotton yarn is 0.2 mm
- the distance between the surface of the cotton yarn to which the nickel chelate is immobilized and the surface of the nylon yarn to which the cage DNA is immobilized is in the range of about 0 to 0.2 mm.
- Cotton yarn was wound three times per 5mm nylon yarn.
- the composite yarn was washed with 1% SDS / lxSSC, washed with 10 mM Tris-HCl (pH 7.5), and then used.
- the composite yarn after the RTS reaction was washed with 20 mM imidazole / PBS buffer, immersed in 0.5% blocking rea gent (Roche) for 30 minutes, and washed with PBS buffer. Then, immerse in POD (peroxidase) -labeled anti-His antibody, anti-GFP antibody, and anti-GST antibody diluted in PBS for 30 minutes, and relax with PBS.
- POD peroxidase
- the composite yarn subjected to the RTS reaction was unwound and only the cotton yarn was taken out, and the protein immobilized on the cotton yarn was detected using a fluorescently labeled antibody.
- Cotton yarn is washed with 20 mM imidazole / PBS, soaked in 1% block ace / PBS for 30 minutes, washed with PBS, and diluted 100-fold with 1% bio ace ace / PBS.
- Anti-GFP antibody and anti-GST antibody Soaked for 30 minutes.
- spots 9 spots (spots 1-9) were confirmed, and 5 spots (spots 1, 3, 5, 7, 9) were confirmed every other spot when detected with anti-GFP antibody. It was. Since each signal is detected independently, protein contamination between spots is None or very low was expected.
- Figure 4 (b) shows a schematic diagram of a composite thread with immobilized GFP-His ⁇ type DNA or GST-His ⁇ type DNA.
- spots 9 spots (spots 1-9) were confirmed, and 5 spots (spots 1, 3, 5, 7, 9) were confirmed every other spot when detected with anti-GFP antibody.
- spots 9 spots (spots 1-9) were confirmed, and 5 spots (spots 1, 3, 5, 7, 9) were confirmed every other spot when detected with anti-GFP antibody.
- anti-GST antibody four spots (spots 2, 4, 6, 8) were confirmed every other place.
- each signal was detected independently, it was predicted that there was no or very low protein contamination between spots.
- Example 2 uses an in vitro transcription / translation system with a single cotton thread in which nickel chelate and cage DNA are immobilized, and the His-tagged protein expressed from the cage DNA is immobilized on the cotton thread.
- the cotton yarn activity was carried out in the same manner as in Example 1, and the chelate yarn and antibody coupling were carried out as follows.
- FIG. 6 (a) shows a schematic diagram of a cotton thread to which nickel chelate and cage DNA are immobilized.
- the cotton yarn in which the nickel chelate and the cocoon-type DNA were immobilized was used in the in vitro transcription / translation system using RTS in the same manner as in Example 1 to express the protein.
- the reaction solution was prepared according to the protocol supplied with the Roche kit and reacted at 37 ° C for 2 hours. After the reaction, detection with a fluorescent-labeled antibody was performed in the same manner as in Example 1.
- Example 3 uses an in vitro transcription / translation system with a single cotton thread with nickel chelate and anchored DNA immobilized on it, and the His-tagged protein expressed from the anchored DNA is immobilized on the cotton thread.
- FIG. 7 shows a schematic diagram of the structure of each cage DNA used in Example 3. His-GST-type DNA (sequence
- ⁇ gal (L) -His-type DNA is glutathione s
- Hi s -BAP-type DNA is a Linear template generation set, manufactured by Roche
- the sample was then immersed in 2 g / ml POD-labeled dartathione for 30 minutes. After washing with PBS buffer, 10 ⁇ l of EC L Detection Reagents was added and measurement was performed with ARGUS (Hamamatsu Photonicus).
- the fixed yarn was blocked with 1% block ace and immersed in 50 ⁇ g / ml j8 galactosidase for 30 minutes. After washing with PBS buffer, it was immersed in 100 times diluted anti
- CDP-Star reagent containing a luminescent substrate was added and the luminescence signal was measured.
- the luminescence signal was observed specifically for His-BAP-type DNA.
- the BAP protein has activity as a dimer, suggesting that the expressed protein can form a homodimer on the thread.
- Example 4 is an example in which protein expression and immobilization were examined in the case of using a planar carrier having cellulose membrane (cellophane) force made of cellulose similar to cotton yarn.
- the anchor-shaped fixation on the cellulose membrane and the expression of the protein by the in vitro transcription / translation system were performed in the same manner as in Example 2 except for the spots of 10% Block ace and 10% Ficoll.
- the RTS reaction was carried out in a state in which 25 1 RTS reaction solution per 1 cm 2 was placed on the membrane, the surface was covered with a film to prevent drying, and the humidity was maintained.
- each cell was detected using an antibody.
- the signal derived from GFP-His was detected on the loin membrane, but the signal of GST-His
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Computational Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
核酸ライブラリー及びタンパク質ライブラリー Nucleic acid library and protein library
技術分野 Technical field
[0001] 本発明は、固体支持体の表面に固定された複数の核酸を含む核酸ライブラリー( 核酸の集合物)、及び固体支持体の表面にディスプレイ (提示)された複数のタンパ ク質を含むタンパク質ライブラリー (タンパク質の集合物)に関する。 [0001] The present invention relates to a nucleic acid library (aggregate of nucleic acids) containing a plurality of nucleic acids immobilized on the surface of a solid support, and a plurality of proteins displayed (presented) on the surface of the solid support. Containing protein libraries (aggregates of proteins).
背景技術 Background art
[0002] プロテオミックスにお 、ては、複数種類のタンパク質に関して、その構造、機能等に 関する多種多様な解析を並列して行なうこと (すなわちハイスループット解析)が必要 となる。複数種類のタンパク質の解析を並列して行なう上で、固体支持体表面に複数 種類のタンパク質が固定されたプロテインアレイ (プロテインチップ)の有用性が注目 されている。プロテインアレイは、複数種類のタンパク質が固体支持体表面の所定領 域に固定されており、タンパク質の種類をタンパク質の固定位置によって識別できる ようになつている。プロテインアレイは、例えば、複数種類のタンパク質の中から、標 的物質 (例えばタンパク質、 DNA等)と結合できるタンパク質をスクリーニングする際 に有用である。 In proteomics, it is necessary to perform a wide variety of analyzes on the structure, function, etc. of multiple types of proteins in parallel (ie, high-throughput analysis). The usefulness of protein arrays (protein chips), in which multiple types of proteins are immobilized on the surface of a solid support, is attracting attention when analyzing multiple types of proteins in parallel. In the protein array, a plurality of types of proteins are fixed in a predetermined region on the surface of the solid support, and the types of proteins can be identified by the fixing positions of the proteins. The protein array is useful, for example, for screening proteins that can bind to a target substance (for example, protein, DNA, etc.) from a plurality of types of proteins.
[0003] し力しながら、従来のプロテインアレイにおいては、固体支持体表面にタンパク質を 固定する際、固体支持体表面へのタンパク質の非効率的なスポッティングを行う必要 がめつた。 [0003] However, in the conventional protein array, when the protein is immobilized on the surface of the solid support, it is necessary to perform inefficient spotting of the protein on the surface of the solid support.
[0004] また、従来のプロテインアレイにおいては、固体支持体表面に固定されたタンパク 質が乾燥により変性及び失活を生じやすぐ固体支持体表面に固定されたタンパク 質がー且変性や失活を起こすと、そのタンパク質を再生させるのは困難であるため、 長期間にわたる保存や使用が困難であった。 [0004] In the conventional protein array, the protein immobilized on the surface of the solid support is denatured and deactivated by drying, and the protein immobilized on the surface of the solid support is immediately denatured and deactivated. When this occurs, it is difficult to regenerate the protein, so it has been difficult to store and use it for a long time.
[0005] さらに、従来のプロテインアレイを用いたアツセィ系では、供給されたタンパク質を 固体支持体表面に固定して初めて解析を行なうことができるので、タンパク質の供給 後直ちに解析を開始することはできず、タンパク質の供給力も解析開始に至るまでに 多大な時間と労力を必要としていた。すなわち、タンパク質の供給とタンパク質のアツ セィ系とが別個独立した技術となっていたため、タンパク質の解析を効率的に進める ことが困難であった。 [0005] Furthermore, in the assembly system using the conventional protein array, the analysis can be started immediately after the protein is supplied because the analysis can be performed only after the supplied protein is fixed on the surface of the solid support. In addition, the protein supply power required a lot of time and effort to start the analysis. That is, protein supply and protein It was difficult to efficiently analyze proteins because it was a separate and independent technology.
[0006] このような状況の下、互いに離反した状態で存在する 2種類以上のライブラリーュ- ットを有する核酸ライブラリーであって、各ライブラリーユニットが、 in vitro転写'翻訳 系又は in vitro翻訳系において 1種類以上のタンパク質を発現し得る核酸と、該核酸 に近接して設けられたタンパク質捕獲体とを含んで構成されており、各ライブラリーュ ニットが固体支持体の表面に設けられ、各ライブラリーユニットに含まれる核酸が、各 ライブラリーユニットが設けられた固体支持体の表面に固定されている核酸ライブラリ 一が開発されて!ヽる (特許文献 1参照)。 [0006] Under such circumstances, a nucleic acid library having two or more types of library sets that exist in a state of being separated from each other, wherein each library unit has an in vitro transcription'translation system or in vitro translation. The system comprises a nucleic acid capable of expressing one or more kinds of proteins and a protein trap provided in the vicinity of the nucleic acid. Each library unit is provided on the surface of a solid support, and A nucleic acid library in which nucleic acids contained in a rally unit are fixed on the surface of a solid support provided with each library unit has been developed (see Patent Document 1).
[0007] 上記核酸ライブラリーにおいては、異なる種類のライブラリーユニットが互いに離反 した状態で存在するとともに、各ライブラリーユニットにおいてタンパク質捕獲体が核 酸に近接して設けられて 、るので、異なる種類のライブラリーユニットに含まれる核酸 とタンパク質捕獲体との距離は、同一のライブラリーユニットに含まれる核酸とタンパ ク質捕獲体との距離よりも圧倒的に大きくなつている。したがって、各ライブラリーュ- ットに含まれる核酸力も発現されるタンパク質は、異なる種類のライブラリーユニットに 含まれるタンパク質捕獲体よりも、同一のライブラリーユニットに含まれるタンパク質捕 獲体に優先的に捕獲され、異なる種類のライブラリーユニットで発現されるタンパク質 のクロスコンタミネーシヨンを効果的に防止することができる。よって、上記核酸ライブ ラリーが有する 2種類以上のライブラリーユニットを in vitro転写'翻訳系又は in vitro 翻訳系に供すると、各ライブラリーユニットに含まれる核酸力 発現されたタンパク質 は、同一のライブラリーユニットに含まれるタンパク質捕獲体に捕獲された状態で固 体支持体上にディスプレイ (提示)される。すなわち、上記核酸ライブラリーによれば、 複数種類のタンパク質を、それをコードする核酸と対応付けた状態で、かつ固体支 持体上にディスプレイされた状態で一度に供給でき、これにより複数種類のタンパク 質の解析を並列して効率よく行なうことができる。 [0007] In the nucleic acid library, different types of library units exist in a state of being separated from each other, and protein capture bodies are provided in close proximity to the nucleic acid in each library unit. The distance between the nucleic acid contained in the library unit and the protein capture body is overwhelmingly larger than the distance between the nucleic acid contained in the same library unit and the protein capture body. Therefore, proteins that also express nucleic acid strength in each library unit are preferentially captured by protein catchers contained in the same library unit over protein catchers contained in different types of library units. Thus, cross-contamination of proteins expressed in different types of library units can be effectively prevented. Therefore, when two or more types of library units possessed by the above-mentioned nucleic acid library are subjected to an in vitro transcription 'translation system or an in vitro translation system, the nucleic acid-expressed proteins contained in each library unit are identical to the same library. It is displayed (presented) on the solid support while being captured by the protein trap contained in the unit. That is, according to the nucleic acid library, a plurality of types of proteins can be supplied at a time in a state in which they are associated with nucleic acids encoding them and displayed on a solid support. Protein analysis can be performed efficiently in parallel.
[0008] また、上記核酸ライブラリ一は、各ライブラリーユニットを in vitro転写 ·翻訳系又は in vitro翻訳系に供することにより直ちにタンパク質ライブラリーに変換される。すなわち 、上記核酸ライブラリーにおいては、タンパク質の供給とタンパク質のアツセィ系とが 一体となっているので、複数種類のタンパク質の供給後、直ちに当該複数種類のタ ンパク質の解析を行なうことができる。 [0008] The nucleic acid library is immediately converted into a protein library by subjecting each library unit to an in vitro transcription / translation system or an in vitro translation system. In other words, in the nucleic acid library, protein supply and protein assembly are Since they are integrated, the plurality of types of proteins can be analyzed immediately after the supply of a plurality of types of proteins.
[0009] さらに、上記核酸ライブラリーにおいては、固体支持体上にディスプレイされたタン パク質が変性や失活を起こしたとしても、そのタンパク質に対応する核酸を再度発現 させることにより、タンパク質を容易に再生することができる。 [0009] Furthermore, in the above-described nucleic acid library, even if the protein displayed on the solid support is denatured or inactivated, the protein can be easily expressed by re-expressing the nucleic acid corresponding to the protein. Can be played.
特許文献 1:国際公開 WO03Z083111号パンフレット Patent Document 1: International Publication WO03Z083111 Pamphlet
発明の開示 Disclosure of the invention
発明が解決しょうとする課題 Problems to be solved by the invention
[0010] 特許文献 1では、例えば、ライブラリーユニットごとに核酸とタンパク質捕獲体とを近 接して設けるために、核酸の一端を固体支持体に固定し、核酸の他端にタンパク質 捕獲体を設け、核酸とタンパク質捕獲体との位置関係を対応付けている。このように、 ライブラリーユニットごとに核酸とタンパク質捕獲体との位置関係を対応付けてライブ ラリーユニットを形成すると、核酸ライブラリーの作製効率が低くなる。 [0010] In Patent Document 1, for example, in order to provide a nucleic acid and a protein capture body close to each library unit, one end of the nucleic acid is fixed to a solid support, and a protein capture body is provided at the other end of the nucleic acid. The positional relationship between the nucleic acid and the protein capturing body is associated. Thus, when the library unit is formed by associating the positional relationship between the nucleic acid and the protein trap for each library unit, the efficiency of producing the nucleic acid library is lowered.
[0011] そこで、本発明は、複数種類のタンパク質を、それをコードする核酸と対応付けて 一度に供給することができるとともに、複数種類のタンパク質の供給後、直ちに当該 複数種類のタンパク質の解析を並列して行なうことができ、しかも変性や失活を起こ したタンパク質を容易に再生することができる核酸ライブラリーであって、その作製の 際に核酸とタンパク質捕獲体との位置関係を対応付ける必要がなぐ効率的な作製 が可能である核酸ライブラリー及びその作製方法を提供することを目的とする。 [0011] Thus, the present invention can supply a plurality of types of proteins at once in association with the nucleic acids that encode them, and immediately analyze the plurality of types of proteins after supplying the plurality of types of proteins. It is a nucleic acid library that can be performed in parallel and can easily regenerate proteins that have been denatured or inactivated, and it is necessary to associate the positional relationship between the nucleic acid and the protein trap in the production. It is an object of the present invention to provide a nucleic acid library that can be efficiently produced and a method for producing the same.
[0012] また、本発明は、本発明の核酸ライブラリーを利用して作製されたタンパク質ライブ ラリー、及び本発明の核酸ライブラリーを利用したタンパク質ライブラリーの作製方法 を提供することを目的とする。 [0012] Another object of the present invention is to provide a protein library prepared using the nucleic acid library of the present invention, and a method for preparing a protein library using the nucleic acid library of the present invention. .
課題を解決するための手段 Means for solving the problem
[0013] 上記課題を解決するために、本発明は、第 1の固体支持体と、前記第 1の固体支持 体の所定表面領域に固定された、 in vitro転写 ·翻訳系又は in vitro翻訳系において 互いに異なる種類のタンパク質を発現できる複数の核酸群と、第 2の固体支持体と、 前記第 2の固体支持体の所定表面領域に高密度で固定された、前記複数の核酸群 力も発現されるいずれのタンパク質をも捕獲できる複数のタンパク質捕獲体とを備え た核酸ライブラリーであって、前記複数の核酸群は、それぞれ、前記所定表面領域 に互いに離反して存在する複数の部分領域のうち一の部分領域に固定されており、 前記複数のタンパク質捕獲体が固定された前記所定表面領域が、前記複数の核酸 群が固定された前記所定表面領域に近接するように、前記第 1の固体支持体に対し て前記第 2の固体支持体が配置された核酸ライブラリーを提供する。 [0013] In order to solve the above-mentioned problems, the present invention provides a first solid support and an in vitro transcription / translation system or in vitro translation system fixed to a predetermined surface region of the first solid support. A plurality of nucleic acid groups capable of expressing different types of proteins in the second solid support, and the plurality of nucleic acid groups fixed to the predetermined surface region of the second solid support at a high density. With multiple protein traps that can capture any protein Each of the plurality of nucleic acid groups is fixed to one partial region of the plurality of partial regions that are separated from each other on the predetermined surface region, and the plurality of protein capture bodies The second solid support is arranged with respect to the first solid support so that the predetermined surface region to which the plurality of nucleic acid groups are fixed is close to the predetermined surface region to which the plurality of nucleic acid groups are fixed. A nucleic acid library is provided.
[0014] 本発明の核酸ライブラリーでは、複数のタンパク質捕獲体が高密度で固定された第 2の固体支持体の所定表面領域 (以下「タンパク質捕獲体固定表面領域」と!、う場合 がある)が、複数の核酸群が互いに離反した状態で固定された第 1の固体支持体の 所定表面領域 (以下「核酸固定表面領域」という場合がある)に近接しているので、各 核酸群には、核酸群ごとに異なるタンパク質捕獲体が近接しており、一の核酸群と一 の核酸群に近接するタンパク質捕獲体との距離は、他の核酸群と一の核酸群に近接 するタンパク質捕獲体との距離よりも圧倒的に小さくなつている。なお、各タンパク質 捕獲体は、各核酸群から発現されるいずれのタンパク質をも捕獲できるので、各核酸 群には、 、ずれのタンパク質捕獲体が近接して 、てもよ 、。 [0014] In the nucleic acid library of the present invention, there is a case where a predetermined surface region of the second solid support (hereinafter referred to as "protein capturer fixed surface region"!) Is fixed. ) Is close to a predetermined surface region (hereinafter sometimes referred to as “nucleic acid immobilization surface region”) of the first solid support in which a plurality of nucleic acid groups are immobilized in a state of being separated from each other. The different protein capture bodies for each nucleic acid group are close to each other, and the distance between one nucleic acid group and a protein capture body close to one nucleic acid group It is overwhelmingly smaller than the distance to the body. Since each protein capturer can capture any protein expressed from each nucleic acid group, each nucleic acid group may be in close proximity to a different protein capturer.
[0015] したがって、本発明の核酸ライブラリーを in vitro転写 ·翻訳系又は in vitro翻訳系に 供すると、各核酸群から発現されたタンパク質は、各核酸群に近接するタンパク質捕 獲体に優先的に捕獲されるので、各核酸群から発現されたタンパク質のクロスコンタ ミネーシヨンは防止される。すなわち、本発明の核酸ライブラリーによれば、複数種類 のタンパク質を、それをコードする核酸と対応付けた状態で第 2の固体支持体上にデ イスプレイでき、これにより、複数種類のタンパク質の解析を並列して効率よく行なうこ とがでさる。 [0015] Therefore, when the nucleic acid library of the present invention is subjected to an in vitro transcription / translation system or an in vitro translation system, the protein expressed from each nucleic acid group has priority over the protein catcher adjacent to each nucleic acid group. Therefore, cross-contamination of proteins expressed from each nucleic acid group is prevented. That is, according to the nucleic acid library of the present invention, a plurality of types of proteins can be displayed on the second solid support in a state in which they are associated with the nucleic acids that encode them, thereby analyzing a plurality of types of proteins. Can be performed efficiently in parallel.
[0016] また、本発明の核酸ライブラリ一は、 in vitro転写 ·翻訳系又は in vitro翻訳系に供す ることにより直ちにタンパク質ライブラリーに変換される。すなわち、本発明の核酸ライ ブラリーにおいては、タンパク質の供給とタンパク質のアツセィ系とがー体となってい る。したがって、本発明の核酸ライブラリーによれば、複数種類のタンパク質の供給 後、直ちに当該複数種類のタンパク質の解析を行なうことができる。 [0016] Further, the nucleic acid library of the present invention is immediately converted into a protein library by subjecting it to an in vitro transcription / translation system or an in vitro translation system. That is, in the nucleic acid library of the present invention, the protein supply and the protein assembly are in the form of a body. Therefore, according to the nucleic acid library of the present invention, it is possible to analyze the plurality of types of proteins immediately after supplying the plurality of types of proteins.
[0017] さらに、本発明の核酸ライブラリーによれば、第 2の固体支持体上にディスプレイさ れたタンパク質が変性や失活を起こしたとしても、そのタンパク質に対応する核酸群 を再度発現させることにより、タンパク質を容易に再生することができる。 [0017] Furthermore, according to the nucleic acid library of the present invention, even if the protein displayed on the second solid support is denatured or inactivated, the nucleic acid group corresponding to the protein is collected. By re-expressing the protein, the protein can be easily regenerated.
[0018] さらに、本発明の核酸ライブラリーの作製にあたり、第 1の固体支持体の所定表面 領域に複数の核酸群を互いに離反した状態で固定する工程により核酸固定表面領 域を形成させ、第 2の固体支持体の所定表面領域に複数のタンパク質捕獲体を高密 度で固定する工程によりタンパク質捕獲体固定表面領域を形成させ、タンパク質捕 獲体固定表面領域が核酸固定表面領域に近接するように、第 1の固体支持体に対 して第 2の固体支持体を配置すればよい。すなわち、タンパク質捕獲体を各核酸群 の位置と対応付けて配列させる必要はなぐ各核酸群の位置に関係なくランダムに 配列させればよい。したがって、本発明の核酸ライブラリ一は効率的に作製すること ができる。 [0018] Further, in preparing the nucleic acid library of the present invention, a nucleic acid fixing surface region is formed by a step of fixing a plurality of nucleic acid groups in a state of being separated from each other to a predetermined surface region of the first solid support. The protein capturer immobilization surface region is formed by fixing a plurality of protein capturers at a high density on the predetermined surface region of the solid support 2 so that the protein capturer immobilization surface region is close to the nucleic acid immobilization surface region. The second solid support may be disposed with respect to the first solid support. That is, the protein traps need not be arranged in association with the positions of the nucleic acid groups, and may be arranged randomly regardless of the positions of the nucleic acid groups. Therefore, the nucleic acid library of the present invention can be produced efficiently.
[0019] 本発明の核酸ライブラリーにおいて、タンパク質捕獲体は、隣接するタンパク質捕 獲体間の距離が、互いに離反して存在する複数の部分領域のうち隣接する部分領 域間の距離よりも圧倒的に小さくなるような密度で第 2の固体支持体の所定表面領域 に固定され、第 2の固体支持体は、核酸固定表面領域とタンパク質捕獲体固定表面 領域との距離が、互いに離反して存在する複数の部分領域のうち隣接する部分領域 間の距離よりも圧倒的に小さくなるように、第 1の固体支持体に対して配置される。こ れにより、各核酸群力も発現されたタンパク質のクロスコンタミネーシヨンを効果的に 防止することができる。 [0019] In the nucleic acid library of the present invention, the protein capture body is overwhelmed by the distance between adjacent protein capture bodies than the distance between adjacent partial areas among a plurality of partial areas that are separated from each other. The second solid support is fixed to a predetermined surface area of the second solid support with such a density that the distance between the nucleic acid fixation surface area and the protein capturer fixation surface area is separated from each other. It arrange | positions with respect to a 1st solid support body so that it may become overwhelmingly smaller than the distance between adjacent partial areas among several existing partial areas. This effectively prevents cross-contamination of proteins in which each nucleic acid group force is also expressed.
[0020] 互いに離反して存在する複数の部分領域のうち隣接する部分領域間の距離は特 に限定されるものではないが、通常 0. Olmm以上、好ましくは 0. 1mm以上、さらに 好ましくは lmm以上である。隣接する部分領域間の距離の上限値は特に限定され るものではなぐ第 1の固体支持体の所定表面領域の大きさ等に応じて適宜調節す ることができるが、通常 10mmである。なお、「部分領域間の距離」とは、 2つの部分 領域の周縁のうち最も近接する 2点間の距離を意味する。 [0020] The distance between adjacent partial areas among a plurality of partial areas that are separated from each other is not particularly limited, but is usually not less than 0. Olmm, preferably not less than 0.1 mm, more preferably lmm. That's it. The upper limit value of the distance between the adjacent partial regions is not particularly limited, and can be appropriately adjusted according to the size of the predetermined surface region of the first solid support, but is usually 10 mm. The “distance between partial areas” means the distance between the two closest points in the periphery of the two partial areas.
[0021] タンパク質捕獲体は、隣接するタンパク質捕獲体間の距離が、互いに離反して存 在する複数の部分領域のうち隣接する部分領域間の距離の 100分の 1以下となるよ うな密度で、第 2の固体支持体の所定表面領域に固定されていることが好ましい。隣 接するタンパク質捕獲体間の距離は、互いに離反して存在する複数の部分領域のう ち隣接する部分領域間の距離の 100分の 1以下、 1000分の 1以下、 1万分の 1以下 、 10万分の 1以下、 100万分の 1以下、 1000万分の 1以下というように、小さくなれば なるほど好ましい。 [0021] The protein capture body has a density such that the distance between adjacent protein capture bodies is 1/100 or less of the distance between adjacent partial areas among a plurality of partial areas that are separated from each other. The second solid support is preferably fixed to a predetermined surface region. The distance between adjacent protein traps is the distance between multiple partial regions that are separated from each other. 1/100, 1 / 10,000, 1 / 10,000 or less, 1 / 100,000, 1 / 1,000,000 or less, 1 / 10,000,000 or less. The better.
[0022] 第 2の固体支持体は、タンパク質捕獲体固定表面領域と核酸固定表面領域との距 離が、互いに離反して存在する複数の部分領域のうち隣接する部分領域間の距離 の 5分の 1以下となるように、第 1の固体支持体に対して配置されていることが好まし い。タンパク質捕獲体固定表面領域と核酸固定表面領域との距離は、互いに離反し て存在する複数の部分領域のうち隣接する部分領域間の距離の 5分の 1以下、 50分 の 1以下、 500分の 1以下、 5000分の 1以下というように、小さくなればなるほど好ま しい。なお、タンパク質捕獲体固定表面領域と核酸固定表面領域との距離の下限値 は 0である。 [0022] The second solid support is such that the distance between the protein capturer-immobilized surface region and the nucleic acid-immobilized surface region is 5 minutes of the distance between adjacent partial regions among a plurality of partial regions that are separated from each other. It is preferable that it is arranged with respect to the first solid support so that it is 1 or less. The distance between the surface area for immobilizing the protein capturer and the surface area for immobilizing the nucleic acid is 1/5 or less, 50 minutes or less, and 500 minutes or less of the distance between adjacent partial areas that are separated from each other. The smaller it is, the better it is. The lower limit of the distance between the protein capturer fixed surface region and the nucleic acid fixed surface region is zero.
[0023] 本発明の核酸ライブラリーにおいて、第 1及び第 2の固体支持体の形状、第 1の固 体支持体に対する第 2の固体支持体の配置の仕方等は、タンパク質捕獲体固定表 面領域を核酸固定表面領域に近接させることができる限り特に限定されるものではな いが、本発明の核酸ライブラリーの好ましい態様においては、第 2の固体支持体が可 撓性長尺部材からなり、第 2の固体支持体が第 1の固体支持体に螺旋状に卷装され て 、る (本態様を以下「第 1の態様」という)。 [0023] In the nucleic acid library of the present invention, the shape of the first and second solid supports, the arrangement of the second solid support relative to the first solid support, and the like are as follows. The region is not particularly limited as long as the region can be brought close to the nucleic acid immobilization surface region, but in a preferred embodiment of the nucleic acid library of the present invention, the second solid support is made of a flexible long member. The second solid support is spirally mounted on the first solid support (this embodiment is hereinafter referred to as “first embodiment”).
[0024] 第 1の態様によれば、第 2の固体支持体の巻き数を調節することにより、核酸固定 表面領域に対するタンパク質捕獲体の配列密度を調節することができ、各核酸群か ら発現されたタンパク質のクロスコンタミネーシヨンを効果的に防止することができる。 なお、第 1の態様においては、第 2の固体支持体の表面におけるタンパク質捕獲体 の固定密度よりも、核酸固定表面領域に対するタンパク質捕獲体の配列密度の方が 大きくなつている。 [0024] According to the first aspect, by adjusting the number of turns of the second solid support, the sequence density of the protein capture body relative to the nucleic acid-fixed surface region can be adjusted, and expression from each nucleic acid group can be achieved. Cross contamination of the produced protein can be effectively prevented. In the first embodiment, the density of the protein traps on the nucleic acid-fixed surface region is larger than the density of the protein traps on the surface of the second solid support.
[0025] また、第 1の態様によれば、隣接する核酸群間に介在する第 2の固体支持体が障 壁となり、各核酸力 発現されたタンパク質のクロスコンタミネーシヨンを効果的に防 止することができる。 [0025] Further, according to the first aspect, the second solid support interposed between adjacent nucleic acid groups serves as a barrier, and effectively prevents cross-contamination of proteins expressed by each nucleic acid force. can do.
[0026] 第 1の態様において、可撓性長尺部材の形状は長尺状である限り特に限定される ものではなぐ例えば、糸状、紐状、テープ状等が挙げられる。 [0027] 第 1の態様において、第 1の固体支持体の形状は可撓性長尺部材を卷装できる限 り特に限定されるものではなぐ例えば、平板状、円柱状、円筒状、角柱状、角筒状、 棒状、糸状、紐状、テープ状等が挙げられる。 [0026] In the first aspect, the shape of the flexible long member is not particularly limited as long as it is long, and examples thereof include a thread shape, a string shape, and a tape shape. [0027] In the first aspect, the shape of the first solid support is not particularly limited as long as the flexible long member can be equipped. For example, a flat plate shape, a cylindrical shape, a cylindrical shape, a prismatic shape , Rectangular tube shape, rod shape, thread shape, string shape, tape shape and the like.
[0028] 第 1の態様において、第 2の固体支持体の巻き数は、タンパク質固定表面領域が 各核酸群に近接する限り特に限定されるものではないが、例えば、互いに離反して 存在する複数の部分領域の巻き軸方向の長さのうち、最も短い長さを巻き軸方向単 位長さとしたとき、巻き軸方向単位長さあたりの第 2の固体支持体の巻き数は、好まし くは 1回以上、さらに好ましくは 2回以上である。巻き軸方向単位長さあたりの第 2の 固体支持体の巻き数の上限値は特に限定されるものではなぐ第 2の固体支持体の 幅に応じて適宜調節することができる。各部分領域の巻き軸方向の長さは特に限定 されるものではないが、通常 0. 05mm以上、好ましくは 2mm以上である。各部分領 域の巻き軸方向の長さの上限値は特に限定されるものではなぐ第 1の固体支持体 の大きさ等に応じて適宜調節することができる力 通常 10mmである。第 2の固体支 持体の幅は巻き軸方向単位長さ以下とし、タンパク質固定表面領域のうち異なる領 域同士が重ならないように第 2の固体支持体を第 1の固体支持体に卷装することが 好ましい。なお、「巻き軸」とは、第 1の固体支持体に卷装された第 2の固体支持体に よって形成される螺旋の中心を通る線を意味する。 [0028] In the first embodiment, the number of windings of the second solid support is not particularly limited as long as the protein-immobilized surface region is close to each nucleic acid group. The number of turns of the second solid support per unit length in the winding axis direction is preferably when the shortest length is the unit length in the winding axis direction. Is at least once, more preferably at least twice. The upper limit value of the number of turns of the second solid support per unit length in the winding axis direction is not particularly limited and can be appropriately adjusted according to the width of the second solid support. The length of each partial region in the winding axis direction is not particularly limited, but is usually 0.05 mm or more, preferably 2 mm or more. The upper limit of the length in the winding axis direction of each partial region is not particularly limited, and is a force that can be appropriately adjusted according to the size of the first solid support and the like, which is usually 10 mm. The width of the second solid support is less than or equal to the unit length in the winding axis direction, and the second solid support is mounted on the first solid support so that different regions of the protein immobilization surface region do not overlap each other. It is preferable to do. The “winding shaft” means a line passing through the center of the spiral formed by the second solid support mounted on the first solid support.
[0029] 本発明の核酸ライブラリーにおいて、第 2の固体支持体が第 1の固体支持体に対し て配置された状態のまま、第 2の固体支持体上にディスプレイされたタンパク質の解 析を行おうとすると、第 2の固体支持体の形状、第 1の固体支持体に対する第 2の固 体支持体の配置の仕方等によっては、第 2の固体支持体がタンパク質解析の障害と なる場合がある。例えば、核酸固定表面領域の全体が第 2の固体支持体によって覆 われている場合、第 2の固体支持体が第 1の固体支持体に対して配置された状態の ままでは、第 2の固体支持体上にディスプレイされたタンパク質へのアクセスが困難 である。このような場合には、タンパク質ライブラリーの作製力もタンパク質ライブラリ 一を利用したタンパク質の解析に至る一連の操作の自動化を図ることが困難である。 [0029] In the nucleic acid library of the present invention, the protein displayed on the second solid support is analyzed while the second solid support is arranged with respect to the first solid support. Depending on the shape of the second solid support, the arrangement of the second solid support relative to the first solid support, etc., the second solid support may become an obstacle to protein analysis. is there. For example, when the entire nucleic acid immobilization surface region is covered by the second solid support, the second solid support remains in a state in which the second solid support is arranged with respect to the first solid support. Access to the protein displayed on the support is difficult. In such a case, it is difficult to automate a series of operations up to protein analysis using the protein library alone as a protein library production ability.
[0030] 本発明の核酸ライブラリーにおいて、核酸固定表面領域全体が第 2の固体支持体 によって覆われている場合としては、例えば、第 2の固体支持体が中空部を有する部 材 (例えば、円筒状、角筒状、「c」の字状、「コ」の字状等に湾曲又は曲折した可撓 性シート状部材)からなり、第 1の固体支持体が第 2の固体支持体の中空部に収容さ れている場合が挙げられる。 [0030] In the nucleic acid library of the present invention, when the entire nucleic acid immobilization surface region is covered with the second solid support, for example, the second solid support has a hollow part. Material (for example, a flexible sheet-like member curved or bent into a cylindrical shape, a rectangular tube shape, a `` c '' shape, a `` U '' shape, etc.), and the first solid support is the second The case where it is accommodated in the hollow part of a solid support is mentioned.
[0031] これに対して、第 1の態様においては、第 2の固体支持体が第 1の固体支持体に対 して配置された状態のままでも、第 2の固体支持体上にディスプレイされたタンパク質 へのアクセスが容易である。したがって、第 1の態様によれば、タンパク質ライブラリー の作製カゝらタンパク質ライブラリーを利用したタンパク質の解析に至る一連の操作の 自動化を容易に図ることができる。 [0031] On the other hand, in the first aspect, the second solid support is displayed on the second solid support even when the second solid support remains arranged with respect to the first solid support. Easy access to proteins. Therefore, according to the first aspect, it is possible to easily automate a series of operations up to protein analysis using a protein library.
[0032] 本発明の核酸ライブラリーにおいて、第 1の固体支持体の表面に固定された核酸 の種類を識別する方法は特に限定されるものでないが、本発明の核酸ライブラリーの 好ましい態様においては、第 1の固体支持体の表面における各核酸群の位置と各核 酸群に含まれる核酸の種類とが対応付けられて ヽる (本態様を以下「第 2の態様」と いう)。 [0032] In the nucleic acid library of the present invention, the method for identifying the type of nucleic acid immobilized on the surface of the first solid support is not particularly limited, but in a preferred embodiment of the nucleic acid library of the present invention, The position of each nucleic acid group on the surface of the first solid support is associated with the type of nucleic acid contained in each nucleic acid group (this embodiment is hereinafter referred to as “second embodiment”).
[0033] 第 2の態様によれば、各核酸群に含まれる核酸の種類及び各核酸群から発現され たタンパク質の種類を各核酸群の位置に基づ 、て容易に識別することができる。また 、各核酸群から発現されたタンパク質は各核酸群に近接するタンパク質捕獲体に捕 獲されるので、タンパク質捕獲体に捕獲されたタンパク質の種類は、タンパク質捕獲 体に近接する核酸群の位置に基づ 、て容易に識別することができる。 [0033] According to the second aspect, the type of nucleic acid contained in each nucleic acid group and the type of protein expressed from each nucleic acid group can be easily identified based on the position of each nucleic acid group. In addition, since the protein expressed from each nucleic acid group is captured by a protein capture body close to each nucleic acid group, the type of protein captured by the protein capture body is at the position of the nucleic acid group close to the protein capture body. Based on this, it can be easily identified.
[0034] 本発明の核酸ライブラリーにおいて、タンパク質捕獲体の種類は、各核酸群から発 現されるいずれのタンパク質をも捕獲できる限り特に限定されるものでないが、本発 明の好ましい態様においては、各核酸群から発現されるタンパク質が、核酸群間で 種類が異なる標的タンパク質と、核酸群間で種類が同一のタグタンパク質との融合タ ンパク質であり、各タンパク質捕獲体力タグタンパク質に結合することができる (本態 様を以下「第 3の態様」という)。 [0034] In the nucleic acid library of the present invention, the type of the protein capture body is not particularly limited as long as any protein expressed from each nucleic acid group can be captured, but in a preferred embodiment of the present invention, The protein expressed from each nucleic acid group is a fusion protein of a target protein of a different type between the nucleic acid groups and a tag protein of the same type between the nucleic acid groups, and binds to each protein capture force tag protein (This mode is hereinafter referred to as “third mode”).
[0035] 第 3の態様によれば、各核酸群から発現されるタンパク質とタンパク質捕獲体との結 合が確実なものとなる。なお、「標的タンパク質」とは、第 2の固体支持体上にディスプ レイされ、解析対象となるタンパク質を意味する。 [0035] According to the third aspect, the binding between the protein expressed from each nucleic acid group and the protein trap is ensured. The “target protein” means a protein to be analyzed that is displayed on the second solid support.
[0036] 第 3の態様において、各核酸群から発現された融合タンパク質は、向きが同一とな るようにタンパク質捕獲体と結合することが好ま U、。各核酸群から発現された融合タ ンパク質の向きが同一となることにより、第 2の固体支持体上にディスプレイされた融 合タンパク質の反応性を均一化及び最適化することができる。 [0036] In the third embodiment, the fusion proteins expressed from each nucleic acid group have the same orientation. U, preferred to bind with protein traps. By making the direction of the fusion protein expressed from each nucleic acid group the same, the reactivity of the fusion protein displayed on the second solid support can be made uniform and optimized.
[0037] 本発明は、本発明の核酸ライブラリーを作製する方法であって、前記第 1の固体支 持体の所定表面領域のうち前記複数の部位領域に、それぞれ、前記複数の核酸群 のうち一の核酸群を固定する工程、前記第 2の固体支持体の所定表面領域に、前記 複数のタンパク質捕獲体を高密度で固定する工程、及び、前記複数のタンパク質捕 獲体が固定された前記所定表面領域が、前記複数の核酸群が固定された前記所定 表面領域に近接するように、前記第 1の固体支持体に対して前記第 2の固体支持体 が配置する工程を含む方法を提供する。 [0037] The present invention is a method for producing the nucleic acid library of the present invention, wherein each of the plurality of nucleic acid groups in each of the plurality of site regions of the predetermined surface region of the first solid support is provided. A step of fixing one of the nucleic acid groups, a step of fixing the plurality of protein capturing bodies at a high density to a predetermined surface region of the second solid support, and the plurality of protein capturing bodies being fixed. A method comprising the step of arranging the second solid support relative to the first solid support so that the predetermined surface area is close to the predetermined surface area to which the plurality of nucleic acid groups are fixed. provide.
[0038] 本発明の方法によれば、核酸固定表面領域及びタンパク質捕獲体固定表面領域 をそれぞれ第 1の固体支持体及び第 2の固体支持体に別個に形成させ、タンパク質 捕獲体固定表面領域が核酸固定表面領域に近接するように、第 1の固体支持体に 対して第 2の固体支持体を配置することにより、本発明の核酸ライブラリーを作製する ことができる。すなわち、本発明の核酸ライブラリーの作製にあたり、タンパク質捕獲 体を核酸の位置と対応付けて配列させる必要はなぐ核酸の位置に関係なくランダム に配列させればよい。したがって、本発明の核酸ライブラリーによれば、本発明の核 酸ライブラリーを効率的に作製することができる。 [0038] According to the method of the present invention, the nucleic acid-immobilized surface region and the protein capturer-immobilized surface region are separately formed on the first solid support and the second solid support, respectively. The nucleic acid library of the present invention can be prepared by arranging the second solid support relative to the first solid support so as to be close to the nucleic acid immobilization surface region. That is, in producing the nucleic acid library of the present invention, the protein capture bodies need not be arranged in association with the positions of the nucleic acids, but may be arranged at random regardless of the positions of the nucleic acids. Therefore, according to the nucleic acid library of the present invention, the nucleic acid library of the present invention can be efficiently produced.
[0039] 本発明は、本発明の核酸ライブラリーを in vitro転写 ·翻訳系又は in vitro翻訳系に 供して、前記核酸ライブラリーに含まれる複数の核酸群を一度に発現させることにより 得られるタンパク質ライブラリーを提供する。 [0039] The present invention provides a protein obtained by subjecting the nucleic acid library of the present invention to an in vitro transcription / translation system or an in vitro translation system to express a plurality of nucleic acid groups contained in the nucleic acid library at once. Provide a library.
[0040] 本発明の核酸ライブラリーを in vitro転写 ·翻訳系又は in vitro翻訳系に一度に供し ても、各核酸群力も発現されたタンパク質のクロスコンタミネーシヨンは防止されるの で、複数種類のタンパク質は、それをコードする核酸と対応付けた状態で第 2の固体 支持体上に一度にディスプレイされる。したがって、本発明のタンパク質ライブラリー によれば、複数種類のタンパク質の解析を並列して効率的に行なうことができる。 [0040] Even if the nucleic acid library of the present invention is subjected to an in vitro transcription / translation system or an in vitro translation system all at once, cross-contamination of proteins in which each nucleic acid group force is expressed is prevented. Are displayed at once on a second solid support in association with the nucleic acid encoding them. Therefore, according to the protein library of the present invention, it is possible to efficiently analyze a plurality of types of proteins in parallel.
[0041] また、本発明のタンパク質ライブラリ一は、本発明の核酸ライブラリーに含まれる核 酸群を発現させることによって直ちに作製されるので、複数種類のタンパク質の供給 後、直ちに当該複数種類のタンパク質の解析を行なうことができる。 [0041] In addition, since the protein library of the present invention is immediately prepared by expressing the nucleic acid group contained in the nucleic acid library of the present invention, a plurality of types of proteins can be supplied. Thereafter, the plurality of types of proteins can be analyzed immediately.
[0042] さらに、本発明のタンパク質ライブラリーにおいては、固体支持体上にディスプレイ されたタンパク質が変性や失活を起こしたとしても、そのタンパク質に対応する核酸 群を再度発現させることにより、そのタンパク質を容易に再生することができる。 [0042] Furthermore, in the protein library of the present invention, even if the protein displayed on the solid support is denatured or inactivated, the protein group is expressed by re-expressing the nucleic acid group corresponding to the protein. Can be reproduced easily.
[0043] さらに、本発明のタンパク質ライブラリ一は、核酸ライブラリーの状態で保存しておき 、必要なときにタンパク質ライブラリーを再生させることにより、長期間にわたり繰り返 し使用することがでさる。 [0043] Furthermore, the protein library of the present invention is stored in the state of a nucleic acid library, and can be repeatedly used over a long period of time by regenerating the protein library when necessary.
[0044] 本発明は、本発明の核酸ライブラリーを in vitro転写 ·翻訳系又は in vitro翻訳系に 供して、前記核酸ライブラリーに含まれる複数の核酸群を一度に発現させる工程を含 むタンパク質ライブラリーの作製方法を提供する。 [0044] The present invention provides a protein comprising the step of subjecting the nucleic acid library of the present invention to an in vitro transcription / translation system or in vitro translation system to express a plurality of nucleic acid groups contained in the nucleic acid library at one time. A method for producing a library is provided.
[0045] 本発明のタンパク質ライブラリーの作製方法によれば、各核酸群から発現されたタ ンパク質のクロスコンタミネーシヨンを防止した状態で、本発明のタンパク質ライブラリ 一を作製することができる。 [0045] According to the method for producing a protein library of the present invention, the protein library of the present invention can be produced in a state in which cross-contamination of the protein expressed from each nucleic acid group is prevented.
[0046] 本発明は、固体支持体と、前記固体支持体の所定表面領域に互いに離反した状 態で固定された、 in vitro転写'翻訳系又は in vitro翻訳系において互いに異なる種 類のタンパク質を発現する複数の核酸群と、前記所定表面領域に各核酸群に近接し た状態で固定されたタンパク質捕獲体とを含む核酸ライブラリーを作製する方法であ つて、前記所定表面領域全体に、前記複数の核酸群から発現されるいずれのタンパ ク質をも捕獲できる複数のタンパク質捕獲体を高密度で固定する工程、及び、前記 所定表面領域に互いに離反して存在する複数の部分領域に、それぞれ、前記複数 の核酸群のうち一の核酸群を固定する工程を含む方法を提供する。 [0046] The present invention relates to a solid support and different types of proteins immobilized in a predetermined surface region of the solid support in a state of being separated from each other in an in vitro transcription'translation system or an in vitro translation system. A method for producing a nucleic acid library comprising a plurality of nucleic acid groups to be expressed and a protein trap fixed to the predetermined surface region in the vicinity of each nucleic acid group, wherein the nucleic acid library is formed on the entire predetermined surface region. A step of fixing a plurality of protein capture bodies capable of capturing any protein expressed from a plurality of nucleic acid groups at a high density, and a plurality of partial regions existing apart from each other on the predetermined surface region, respectively. A method comprising the step of immobilizing one nucleic acid group among the plurality of nucleic acid groups is provided.
[0047] 本発明の方法によれば、同一の固体支持体の表面に核酸及びタンパク質捕獲体 を固定する際、タンパク質捕獲体を核酸の位置と対応付けて配列させる必要はなぐ 核酸の位置に関係なくランダムに配列させればょ 、ので、核酸ライブラリーを効率的 に作製することができる。 [0047] According to the method of the present invention, when the nucleic acid and the protein capturing body are immobilized on the surface of the same solid support, it is not necessary to arrange the protein capturing body in association with the position of the nucleic acid. If the sequences are randomly arranged, the nucleic acid library can be efficiently produced.
[0048] 本発明の方法において、固体支持体の所定表面領域への核酸及びタンパク質捕 獲体の固定順序は特に限定されるものではなぐタンパク質捕獲体を固定した後に 核酸を固定してもよ 、し、核酸を固定した後にタンパク質捕獲体を固定してもよ 、。 [0049] 本発明の方法において、複数のタンパク質捕獲体を、複数のタンパク質捕獲体のう ち隣接するタンパク質捕獲体間の距離が、複数の部分領域のうち隣接する部分領域 間の距離の 100分の 1以下となるような密度で固定することが好ましい。これにより、 各核酸群力 発現されたタンパク質のクロスコンタミネーシヨンを効果的に防止するこ とができる。隣接するタンパク質捕獲体間の距離は、互いに離反して存在する複数の 部分領域のうち隣接する部分領域間の距離の 100分の 1以下、 1000分の 1以下、 1 万分の 1以下、 10万分の 1以下、 100万分の 1以下、 1000万分の 1以下というように[0048] In the method of the present invention, the order of immobilization of the nucleic acid and the protein catcher to the predetermined surface region of the solid support is not particularly limited, and the nucleic acid may be immobilized after immobilizing the protein capturer. And you can fix the protein trap after fixing the nucleic acid. [0049] In the method of the present invention, a plurality of protein capture bodies are separated by 100 minutes of the distance between adjacent partial areas of the plurality of partial areas. It is preferable to fix at a density such that it is 1 or less. Thereby, cross-contamination of proteins expressed by each nucleic acid group force can be effectively prevented. The distance between adjacent protein capture bodies is less than 1/100, less than 1/1000, less than 1 / 10,000, and 100,000 minutes Less than 1 / 1,000,000 / 1,000,000 / 1,000,000 or less
、小さくなればなるほど好ましい。 The smaller it is, the better.
[0050] 本発明の方法において、固体支持体は多孔質であることが好ましい。固体支持体 の細孔内は液体 (例えば in vitro転写,翻訳系又は in vitro翻訳系の溶液)の流動性 が低いので、固体支持体の細孔の内部表面に固定された核酸群力 発現されるタン ノ^質は細孔内から放出され難い。したがって、当該核酸群から発現されるタンパク 質をタンパク質捕獲体で確実に捕獲することができ、各核酸群力も発現されたタンパ ク質のクロスコンタミネーシヨンを効果的に防止することができる。 [0050] In the method of the present invention, the solid support is preferably porous. Since the fluidity of the liquid (for example, in vitro transcription, translation system or in vitro translation system) is low in the pores of the solid support, the group of nucleic acids immobilized on the internal surface of the pores of the solid support is expressed. Tungsten is not easily released from the pores. Therefore, the protein expressed from the nucleic acid group can be surely captured by the protein trap, and cross-contamination of the protein in which each nucleic acid group force is expressed can be effectively prevented.
発明の効果 The invention's effect
[0051] 本発明によれば、複数種類のタンパク質を、それをコードする核酸と対応付けて一 度に供給することができるとともに、複数種類のタンパク質の供給後、直ちに当該複 数種類のタンパク質の解析を並列して行なうことができ、し力も変性や失活を起こした タンパク質を容易に再生することができる核酸ライブラリーであって、その作製の際に 核酸とタンパク質捕獲体との位置関係を対応付ける必要がなぐ効率的な作製が可 能である核酸ライブラリーが提供される。また、本発明によれば、本発明の核酸ライブ ラリーを利用して作製されたタンパク質ライブラリーが提供される。さら〖こ、本発明によ れば、本発明の核酸ライブラリーを利用したタンパク質ライブラリーの作製方法が提 供される。 [0051] According to the present invention, a plurality of types of proteins can be supplied at once in association with the nucleic acids that encode them, and the plurality of types of proteins are analyzed immediately after the supply of the plurality of types of proteins. Is a nucleic acid library that can easily regenerate proteins that have undergone denaturation or inactivation, and associates the positional relationship between the nucleic acid and the protein trap during the production. Nucleic acid libraries that can be efficiently produced without need are provided. In addition, according to the present invention, there is provided a protein library prepared using the nucleic acid library of the present invention. Furthermore, according to the present invention, a method for producing a protein library using the nucleic acid library of the present invention is provided.
図面の簡単な説明 Brief Description of Drawings
[0052] [図 1]本発明の一実施形態に係る核酸ライブラリーの斜視図である。 FIG. 1 is a perspective view of a nucleic acid library according to one embodiment of the present invention.
[図 2]各種铸型 DNAの構造の模式図である。 FIG. 2 is a schematic diagram of the structures of various cage DNAs.
[図 3] (a)は複合糸に固定化されたタンパク質を抗 His抗体及び抗 GFP抗体を用いて 検出した結果を示す図であり、 (b)は複合糸の模式図である。 [Figure 3] (a) shows the protein immobilized on the composite yarn using anti-His antibody and anti-GFP antibody. It is a figure which shows the detected result, (b) is a schematic diagram of a composite yarn.
[図 4] (a)は複合糸に固定化されたタンパク質を抗 His抗体、抗 GFP抗体及び抗 GST [Fig. 4] (a) shows the protein immobilized on the composite yarn with anti-His antibody, anti-GFP antibody and anti-GST.
6 6
抗体を用いて検出した結果を示す図であり、 (b)は複合糸の模式図である。 It is a figure which shows the result detected using the antibody, (b) is a schematic diagram of a composite yarn.
[図 5]綿糸に固定ィ匕されたタンパク質を、 Cy5標識抗ゥサギ IgG(H+L)抗体及び AF488 標識抗ネズミ IgG(H+L)抗体を用いて検出した結果を示す図である。 FIG. 5 is a diagram showing the results of detecting proteins immobilized on cotton yarn using Cy5-labeled anti-rabbit IgG (H + L) antibody and AF488-labeled anti-murine IgG (H + L) antibody.
[図 6] (a)はニッケルキレート及び铸型 DNAが固定ィ匕された綿糸の模式図であり、 (b) は綿糸に固定化されたタンパク質を蛍光標識抗体を用いて検出した結果を示す図 である。 [FIG. 6] (a) is a schematic diagram of a cotton yarn in which nickel chelate and cage DNA are immobilized, and (b) shows the result of detecting the protein immobilized on the cotton yarn using a fluorescently labeled antibody. It is a figure.
[図 7]各種铸型 DNAの構造の模式図である。 FIG. 7 is a schematic diagram of the structure of various cage DNAs.
[図 8] (a)は GSTタンパク質のダルタチオン結合能の検出結果を示す図、(b)はアル カリフォスファターゼ活性の検出結果を示す図、(c)は抗 β galactosidase ScFvの抗 体活性の検出結果を示す図である。 [Fig. 8] (a) is a diagram showing the detection results of GST protein for binding to dartathione, (b) is a diagram showing the results of detection of alkaline phosphatase activity, and (c) is a detection of the anti-β galactosidase ScFv antibody activity. It is a figure which shows a result.
[図 9]セルロース膜に固定化されたタンパク質を抗体を用いて検出した結果を示す図 である。 FIG. 9 is a diagram showing the results of detecting the protein immobilized on a cellulose membrane using an antibody.
符号の説明 Explanation of symbols
[0053] 1 · · ·核酸ライブラリー [0053] 1 · · · Nucleic acid library
2—第1の固体支持体 2—First solid support
3…核酸群 3 3 ... Nucleic acid group 3
4· · ·第 2の固体支持体 4 · · · Second solid support
5· · ·タンパク質捕獲体 発明を実施するための最良の形態 5 ··· Protein Capturer BEST MODE FOR CARRYING OUT THE INVENTION
[0054] 以下、本発明の実施形態を図面に基づいて説明する。 Hereinafter, embodiments of the present invention will be described with reference to the drawings.
図 1に示すように、本実施形態に係る核酸ライブラリー 1は、第 1の固体支持体 2と、 第 1の固体支持体 2の所定表面領域に互いに離反した状態で固定された複数の核 酸群 3と、第 1の固体支持体 2に螺旋状に卷装された第 2の固体支持体 4と、第 2の固 体支持体 4の所定表面領域に高密度で固定された複数のタンパク質捕獲体 5とを備 えている。 As shown in FIG. 1, the nucleic acid library 1 according to this embodiment includes a first solid support 2 and a plurality of nuclei fixed to a predetermined surface region of the first solid support 2 in a state of being separated from each other. A plurality of acid groups 3; a second solid support 4 spirally mounted on the first solid support 2; and a plurality of high-density anchors fixed to a predetermined surface region of the second solid support 4 And protein trap 5.
[0055] 図 1に示すように、固体支持体 2の形状は円柱状であるが、固体支持体 2の形状は 、固体支持体 4を卷装可能な形状である限り円柱状に限定されるものではなぐ例え ば、平板状、円筒状、角柱状、角筒状、棒状、紐状、糸状、テープ状等の形状であつ てもよい。 [0055] As shown in FIG. 1, the solid support 2 has a cylindrical shape, but the solid support 2 has a shape of For example, the solid support 4 is not limited to a columnar shape as long as it can be fitted, for example, a flat plate shape, a cylindrical shape, a prismatic shape, a rectangular tube shape, a rod shape, a string shape, a thread shape, a tape shape, etc. It may be in shape.
[0056] 図 1に示すように、固体支持体 4の形状は糸状又は紐状である力 固体支持体 4の 形状は長尺状である限り糸状又は紐状に限定されるものではなぐ例えば、テープ状 であってもよい。固体支持体 4の太さ(直径)は通常 0. 05〜2mm、好ましくは 0. 2〜 lmmで to 。 [0056] As shown in FIG. 1, the solid support 4 has a thread-like or string-like force. The solid support 4 is not limited to a thread-like or string-like shape as long as it is long, for example, It may be in the form of a tape. The thickness (diameter) of the solid support 4 is usually 0.05 to 2 mm, preferably 0.2 to lmm.
[0057] 固体支持体 2を構成する材料は、核酸ライブラリー 1が供される液体 (例えば、 in vit ro転写 ·翻訳系又は in vitro翻訳系の溶液)に対して不溶性である限り特に限定され るものではない。また、固体支持体 4を構成する材料は、核酸ライブラリー 1が供され る液体に対して不溶性であり、かつ固体支持体 4に可撓性を付与できる限り特に限 定されるものではない。なお、固体支持体 2を構成する材料は、固体支持体 2に可撓 性を付与できる材料及び付与できな 、材料の!/、ずれであってもよ!/、。 [0057] The material constituting the solid support 2 is not particularly limited as long as it is insoluble in the liquid to which the nucleic acid library 1 is provided (for example, in vitro transcription / translation system or in vitro translation system solution). It is not something. Further, the material constituting the solid support 4 is not particularly limited as long as it is insoluble in the liquid to which the nucleic acid library 1 is provided and can give the solid support 4 flexibility. The material constituting the solid support 2 may be a material that can impart flexibility to the solid support 2 or a material that cannot be imparted!
[0058] 固体支持体 2又は 4を構成する材料としては、例えば、ガラス;シリコーン;セラミック ス;ポリスチレン等のポリスチレン系榭脂、ポリメチルメタタリレート等の (メタ)アクリル 榭脂、ナイロン 6、ナイロン 66等のポリアミド榭脂、ポリエチレンテレフタレート等のポリ エステル、ポリカーボネート等の合成樹脂;ァガロース、デキストラン、セルロース等の 多糖類;ゼラチン、コラーゲン、カゼイン等のタンパク質が挙げられ、これらのうち 1種 類の材料を単独で又は 2種類以上の材料を組み合わせて使用することができる。 [0058] Examples of the material constituting the solid support 2 or 4 include glass; silicone; ceramics; polystyrene-based resin such as polystyrene; (meth) acrylic resin such as polymethylmetatalate; nylon 6, Polyamides such as nylon 66, polyesters such as polyethylene terephthalate, synthetic resins such as polycarbonate; polysaccharides such as agarose, dextran, and cellulose; proteins such as gelatin, collagen, and casein. The materials can be used alone or in combination of two or more materials.
[0059] 固体支持体 2又は 4は多孔質及び無孔質のいずれであってもよいが、多孔質であ ることが好ましい。多孔質である固体支持体としては、例えば、ナイロン等の合成樹脂 製の固体支持体の表面を塩酸等の酸で処理したもの、繊維の集合体 (例えば繊維を 撚ったもの)等が挙げられる。固体支持体 2又は 4が多孔質である場合、固体支持体 2又は 4の表面積が増加するので、より多くの核酸群 3又はタンパク質捕獲体 5を表面 に固定することができる。 [0059] The solid support 2 or 4 may be either porous or nonporous, but is preferably porous. Examples of the porous solid support include those obtained by treating the surface of a solid support made of a synthetic resin such as nylon with an acid such as hydrochloric acid, and an aggregate of fibers (for example, a twisted fiber). It is done. When the solid support 2 or 4 is porous, the surface area of the solid support 2 or 4 increases, so that more nucleic acid groups 3 or protein capture bodies 5 can be immobilized on the surface.
[0060] 図 1に示すように、固体支持体 2の所定表面領域には、互いに離反して存在する複 数の部分領域が存在しており、複数の核酸群 3は、それぞれ、複数の部分領域のう ち一の部分領域に固定されている。これにより、複数の核酸群 3は、固体支持体 2の 所定表面領域に互いに離反した状態で固定されて 、る。 [0060] As shown in FIG. 1, there are a plurality of partial regions that are separated from each other in the predetermined surface region of the solid support 2, and each of the plurality of nucleic acid groups 3 includes a plurality of portions. It is fixed to one of the areas. As a result, the plurality of nucleic acid groups 3 of the solid support 2 Fixed to a predetermined surface area in a state of being separated from each other.
[0061] 固体支持体 2の表面には、液体 (例えば in vitro転写'翻訳系又は in vitro翻訳系の 溶液)と接触する限り、固体支持体 2の外面 (外部表面)に加え、液体が浸潤する固 体支持体 2の内面(内部表面)(例えば、固体支持体 2が有する細孔の内部表面)も 含まれる。 [0061] The surface of the solid support 2 is infiltrated with the liquid in addition to the outer surface (external surface) of the solid support 2 as long as it comes into contact with the liquid (for example, in vitro transcription'translation system or solution of in vitro translation system). The inner surface (inner surface) of the solid support 2 (for example, the inner surface of the pores of the solid support 2) is also included.
[0062] 互いに離反して存在する複数の部分領域のうち隣接する部分領域間の距離は、通 常 0. 01mm以上、好ましく 0. 1mm以上、さらに好ましくは lmm以上である。なお、 互いに離反して存在する複数の部分領域のうち隣接する部分領域間の距離の上限 値は特に限定されるものではなぐ複数の核酸群 3が固定される所定表面領域の面 積等に応じて適宜調節することができる力 通常 10mmである。 [0062] The distance between adjacent partial regions among the plurality of partial regions that are separated from each other is usually 0.01 mm or more, preferably 0.1 mm or more, and more preferably 1 mm or more. Note that the upper limit of the distance between adjacent partial regions among a plurality of partial regions that are separated from each other is not particularly limited, depending on the area of the predetermined surface region to which a plurality of nucleic acid groups 3 are fixed. The force that can be adjusted appropriately is usually 10mm.
[0063] 各核酸群 3は、 in vitro転写 ·翻訳系又は in vitro翻訳系において互いに異なる種類 のタンパク質を発現する。なお、一の核酸群 3から発現されるタンパク質 (一の核酸群 3から 2種類以上のタンパク質が発現される場合には、少なくとも 1種類のタンパク質) が他の核酸群 3から発現されな 、場合、一の核酸群 3と他の核酸群 3とは互いに異な る種類のタンパク質を発現すると ヽうことができる。一の核酸群 3から発現されるタン パク質が他の核酸群 3から発現されな ヽ場合、各核酸群 3から発現されるタンパク質 のクロスコンタミネーションの問題が生じ得るが、核酸ライブラリ一 1ではこの問題が解 決されている。 [0063] Each nucleic acid group 3 expresses different types of proteins in an in vitro transcription / translation system or in vitro translation system. When a protein expressed from one nucleic acid group 3 (at least one protein when two or more proteins are expressed from one nucleic acid group 3) is not expressed from another nucleic acid group 3. It can be said that one nucleic acid group 3 and another nucleic acid group 3 express different types of proteins. If a protein expressed from one nucleic acid group 3 is not expressed from another nucleic acid group 3, there may be a problem of cross-contamination of proteins expressed from each nucleic acid group 3. This problem has been resolved.
[0064] 固体支持体 2の所定表面領域には、互いに異なる種類のタンパク質を発現する複 数の核酸群 3の他、一の核酸群 3と同一種類のタンパク質のみを発現する核酸群が 固定されていてもよい。一の核酸群 3と同一種類のタンパク質のみを発現する核酸群 は、一の核酸群 3と近接した状態で固体支持体 2の所定表面領域に固定されていて もよいし、一の核酸群 3と離反した状態で固体支持体 2の所定表面領域に固定され ていてもよい。 [0064] In addition to a plurality of nucleic acid groups 3 that express different types of proteins, a nucleic acid group that expresses only the same type of protein as one nucleic acid group 3 is fixed to the predetermined surface region of the solid support 2 It may be. A nucleic acid group that expresses only the same type of protein as one nucleic acid group 3 may be fixed to a predetermined surface region of the solid support 2 in the vicinity of the one nucleic acid group 3, or one nucleic acid group 3 It may be fixed to a predetermined surface region of the solid support 2 in a separated state.
[0065] 各核酸群 3には、各核酸群 3から 1種類又は 2種類以上のタンパク質が発現される ように、同一種類のタンパク質のみを発現する複数の核酸及び/又は異なる種類の タンパク質を発現する複数の核酸が含まれる。同一種類のタンパク質のみを発現す る複数の核酸は、同一構造及び異なる構造のいずれを有しいてもよい。異なる構造 としては、例えば、オープンリーディングフレームは同一である力 転写調節領域又 は翻訳調節領域は異なる構造が挙げられる。 [0065] Each nucleic acid group 3 expresses a plurality of nucleic acids that express only the same type of protein and / or different types of proteins so that one or more types of proteins are expressed from each nucleic acid group 3. A plurality of nucleic acids. A plurality of nucleic acids expressing only the same type of protein may have either the same structure or different structures. Different structure For example, a force transcription control region or translation control region having the same open reading frame may have a different structure.
[0066] タンパク質解析を効率的に行う点からは、各核酸群 3から発現されるタンパク質は 1 種類であることが好まし ヽ。各核酸群 3から発現されるタンパク質が 1種類である場合 、各核酸群 3には、通常、同一種類のタンパク質のみを発現する複数の核酸が含ま れるが、異なる種類のタンパク質を発現する複数の核酸が含まれる場合もある。例え ば、ある核酸群 3から発現されるタンパク質が複数の異なるサブユニットからなる場合 、当該核酸群 3には、各サブユニットを発現する複数の核酸が含まれる。 [0066] From the viewpoint of efficient protein analysis, it is preferable that only one type of protein is expressed from each nucleic acid group 3. When there is one type of protein expressed from each nucleic acid group 3, each nucleic acid group 3 usually includes a plurality of nucleic acids that express only the same type of protein, but a plurality of nucleic acids that express different types of proteins. Nucleic acids may be included. For example, when a protein expressed from a certain nucleic acid group 3 is composed of a plurality of different subunits, the nucleic acid group 3 includes a plurality of nucleic acids that express each subunit.
[0067] 各核酸群 3が in vitro転写'翻訳系又は in vitro翻訳系において発現するタンパク質 は、標的タンパク質とタグタンパク質との融合タンパク質である。 [0067] The protein that each nucleic acid group 3 expresses in an in vitro transcription'translation system or in vitro translation system is a fusion protein of a target protein and a tag protein.
[0068] 標的タンパク質は、固体支持体 4上にディスプレイされ、解析対象となるタンパク質 であり、標的タンパク質の種類は核酸群 3間で異なる。 [0068] The target protein is displayed on the solid support 4 and is the protein to be analyzed. The type of the target protein differs between the nucleic acid groups 3.
[0069] タグタンパク質は、例えば、アビジン、ストレプトアビジン等のピオチン結合タンパク 質、マルトース結合タンパク質、ポリヒスチジンペプチド、グルタチオン S トランス フェラーゼ、カルモジュリン、 ATP結合タンパク質、受容体タンパク質等であり、タグタ ンパク質の種類は核酸群 3間で同一である。 [0069] The tag protein is, for example, a piotin-binding protein such as avidin or streptavidin, a maltose-binding protein, a polyhistidine peptide, a glutathione S-transferase, a calmodulin, an ATP-binding protein, or a receptor protein. The type is the same among nucleic acid groups 3.
[0070] in vitro転写 ·翻訳系においてタンパク質を発現する核酸群には、 DNA及び Z又 は RNAが含まれ、 in vitro翻訳系においてタンパク質を発現する核酸群には、 RNA が含まれる。 [0070] The nucleic acid group that expresses a protein in an in vitro transcription / translation system includes DNA and Z or RNA, and the nucleic acid group that expresses a protein in an in vitro translation system includes RNA.
[0071] in vitro転写 ·翻訳系は、 in vitroにおいて DNAから mRNAへの転写を行なうことが できる in vitro転写系と、 in vitroにおいて mRNAからタンパク質への翻訳を行なうこと 力できる in vitro翻訳系と力 なり、 in vitro転写 ·翻訳系には、転写及び翻訳に必要 な全ての要素(例えば、 RNAポリメラーゼ、リボソーム、 tRNA等)が含まれる。 in vitr o転写 ·翻訳系としては、例えば、真核細胞及び原核細胞の抽出液から調製された無 細胞転写,翻訳系が挙げられ、無細胞転写,翻訳系としては、例えば、大腸菌(例え ば大腸菌 S30)、小麦胚芽、ゥサギ網赤血球、マウス L 細胞、エールリツヒ腹水癌細 胞、 HeLa細胞、 CHO細胞、出芽酵母等の細胞抽出液から調製された無細胞転写 · 翻訳系が挙げられる。 [0072] 各核酸群 3に含まれる核酸の構造は、 in vitro転写 ·翻訳系又は in vitro翻訳系にお いて、核酸群 3間で種類が異なる標的タンパク質と、核酸群 3間で種類が同一のタグ タンパク質との融合タンパク質を発現できる限り特に限定されるものではない。 in vitr o転写 ·翻訳系において目的のタンパク質を発現する核酸としては、例えば、転写調 節領域と、翻訳調節領域と、 目的のタンパク質をコードするオープンリーディングフレ ーム(ORF)と、オープンリーディングフレームの 3'側に設けられた終止コドンとを含 んで構成された DNAが挙げられる。 in vitro翻訳系において目的のタンパク質を発 現する核酸としては、例えば、 in vitro転写 ·翻訳系において目的のタンパク質を発現 する DNAと、チミン (T)力ゥラシル (U)である点を除き同様の構造を有する RNAが 挙げられる。但し、 RNAの場合には転写調節領域は不要である。 [0071] The in vitro transcription / translation system includes an in vitro transcription system capable of performing transcription from DNA to mRNA in vitro, and an in vitro translation system capable of performing translation from mRNA to protein in vitro. In fact, the in vitro transcription / translation system contains all the elements necessary for transcription and translation (eg, RNA polymerase, ribosome, tRNA, etc.). Examples of in vitro transcription / translation systems include cell-free transcription / translation systems prepared from eukaryotic and prokaryotic cell extracts. Examples of cell-free transcription / translation systems include E. coli (for example, Examples include cell-free transcription / translation systems prepared from cell extracts such as E. coli S30), wheat germ, rabbit rabbit reticulocytes, mouse L cells, Ehrlich ascites tumor cells, HeLa cells, CHO cells, and budding yeast. [0072] The structure of the nucleic acid contained in each nucleic acid group 3 is the same in the in vitro transcription / translation system or in vitro translation system, and the target protein is different in the nucleic acid group 3 and the same in the nucleic acid group 3. It is not particularly limited as long as a fusion protein with the tag protein can be expressed. Examples of nucleic acids that express a target protein in an in vitro transcription / translation system include a transcriptional regulatory region, a translational regulatory region, an open reading frame (ORF) encoding the target protein, and an open reading frame. DNA comprising the stop codon provided on the 3 'side of Examples of nucleic acids that express a target protein in an in vitro translation system are the same except for DNA that expresses the target protein in an in vitro transcription / translation system and thymine (T) force uracil (U). And RNA having a structure. However, in the case of RNA, a transcriptional regulatory region is not necessary.
[0073] 転写調節領域及び翻訳調節領域は、それぞれ DNAから mRNAへの転写及び m RNAからタンパク質への翻訳を可能とする限り特に限定されるものではなぐ転写調 節領域としては、例えば、プロモーター、ターミネータ一、ェンノ、ンサ一等が挙げられ 、翻訳調節領域としては、例えば、コザック (kozak)配列、シャイン*ダルガーノ(SD) 配列等が挙げられ、 in vitro転写系の種類、 in vitro翻訳系の種類等に応じて適宜選 択することができる。転写調節領域及び翻訳調節領域は、別個の領域として存在し て!、てもよ 、し重なり合って存在して 、てもよ!/、。 [0073] The transcriptional regulatory region and the translational regulatory region are not particularly limited as long as transcription from DNA to mRNA and translation from mRNA to protein are possible. Examples of transcriptional regulatory regions include promoters, Terminator 1, Enno, Nsa, etc. Examples of translation regulatory regions include Kozak sequence, Shine * Dalgarno (SD) sequence, etc. Types of in vitro transcription systems, in vitro translation systems It can be selected appropriately according to the type. The transcriptional regulatory region and the translational regulatory region may exist as separate regions !, or may overlap and exist! /.
[0074] 目的のタンパク質をコードするオープンリーディングフレーム(ORF)には、標的タン パク質をコードするオープンリーディングフレームと、タグタンパク質をコードするォー プンリーディングフレームとが連結された状態で含まれる。 [0074] An open reading frame (ORF) encoding a protein of interest includes an open reading frame encoding a target protein and an open reading frame encoding a tag protein linked to each other.
[0075] 各核酸群 3に含まれる核酸の具体的な構造としては、例えば、オープンリーデイン グフレームの 5'側にプロモーター及び SD配列を有し、オープンリーディングフレーム の 3'側に終止コドン及びターミネータ一を有する構造が挙げられる。 [0075] The specific structure of the nucleic acid contained in each nucleic acid group 3 includes, for example, a promoter and an SD sequence on the 5 'side of the open reading frame, and a stop codon on the 3' side of the open reading frame. Examples include a structure having a terminator.
[0076] 各核酸群 3に含まれる核酸は二本鎖及び一本鎖の 、ずれの状態で固体支持体 2 の表面に固定されていてもよいが、核酸が DNAである場合、二本鎖の状態で固体 支持体 2の表面に固定されていることが好ましい。ポリメラーゼによる DNAの転写は 二本鎖 DNAを基質として効率的に行なわれるからである。 [0076] The nucleic acid contained in each nucleic acid group 3 may be double-stranded or single-stranded, and may be immobilized on the surface of the solid support 2 in a shifted state. However, when the nucleic acid is DNA, double-stranded In this state, it is preferably fixed to the surface of the solid support 2. This is because transcription of DNA by polymerase is efficiently performed using double-stranded DNA as a substrate.
[0077] 各核酸群 3において、核酸のどの部分が固体支持体 2の表面に固定されていても よいが、核酸の 3'末端又は 5'末端が固体支持体 2の表面に固定されていることが好 ましい。核酸の 3'末端又は 5'末端が固体支持体 2の表面に固定されている場合、核 酸力もタンパク質を効率よく発現させることができる。 [0077] In each nucleic acid group 3, no matter what part of the nucleic acid is immobilized on the surface of the solid support 2 However, it is preferable that the 3 ′ end or 5 ′ end of the nucleic acid is fixed to the surface of the solid support 2. When the 3 ′ end or 5 ′ end of the nucleic acid is immobilized on the surface of the solid support 2, the protein can be efficiently expressed with the nuclear acidity.
[0078] 各核酸群 3の位置は、各核酸群 3に含まれる核酸の種類と対応付けられており、各 核酸群 3に含まれる核酸の種類及び各核酸群 3から発現されるタンパク質の種類は、 各核酸群 3の位置に基づいて識別することができる。 [0078] The position of each nucleic acid group 3 is associated with the type of nucleic acid contained in each nucleic acid group 3, and the type of nucleic acid contained in each nucleic acid group 3 and the type of protein expressed from each nucleic acid group 3. Can be identified based on the position of each nucleic acid group 3.
[0079] 図 1に示すように、固体支持体 4の所定表面領域には、複数のタンパク質捕獲体 5 が高密度で固定されている。 As shown in FIG. 1, a plurality of protein capture bodies 5 are fixed at a high density in a predetermined surface region of the solid support 4.
[0080] 固体支持体 4の表面には、液体(例えば in vitro転写'翻訳系又は in vitro翻訳系の 溶液)と接触する限り、固体支持体 4の外面 (外部表面)に加え、液体が浸潤する固 体支持体 4の内面(内部表面)(例えば、固体支持体 4が有する細孔の内部表面)も 含まれる。 [0080] The surface of the solid support 4 is infiltrated with the liquid in addition to the outer surface (external surface) of the solid support 4 as long as it comes into contact with the liquid (for example, in vitro transcription'translation system or in vitro translation system solution). The inner surface (inner surface) of the solid support 4 (for example, the inner surface of the pores of the solid support 4) is also included.
[0081] タンパク質捕獲体 5は、各核酸群 3から発現される融合タンパク質に含まれるタグタ ンパク質に結合することができる。タグタンパク質 Zタンパク質捕獲体の組み合わせと しては、例えば、アビジン、ストレプトアビジン等のピオチン結合タンパク質 Zピオチン 、マルトース結合タンパク質 Zマルトース、ポリヒスチジンペプチド Zニッケルゃコバル ト等の金属イオン、グルタチオン s トランスフェラーゼ Zグルタチオン、カルモジュ リン Zカルモジュリン結合ペプチド、 ATP結合タンパク質 ZATP、受容体タンパク質 Zリガンド等が挙げられる。各核酸群 3から発現される融合タンパク質には核酸群 3 間で種類が同一のタグタンパク質が含まれるので、タンパク質捕獲体 5は、タグタンパ ク質との結合を介して、各核酸群 3から発現される ヽずれの融合タンパク質をも捕獲 することができる。 [0081] The protein trap 5 can bind to a tag protein contained in the fusion protein expressed from each nucleic acid group 3. Examples of combinations of tag protein Z protein traps include metal ions such as avidin, streptavidin, etc., Piotin-binding protein Z-Piotin, maltose-binding protein Z-maltose, polyhistidine peptide Z nickel-cobalt, glutathione s-transferase Z Glutathione, calmodulin Z calmodulin binding peptide, ATP binding protein ZATP, receptor protein Z ligand and the like. Since the fusion protein expressed from each nucleic acid group 3 includes tag proteins of the same type between the nucleic acid groups 3, the protein trap 5 is expressed from each nucleic acid group 3 through binding to the tag protein. It is possible to capture a few fusion proteins.
[0082] タンパク質捕獲体 5としては、正電荷体又は負電荷体を使用してもよい。タンパク質 は等電点より高い pHでは負に荷電し、等電点より低い PHでは正に荷電するから、タ ンパク質捕獲体 5として正電荷体又は負電荷体を使用することにより、タンパク質捕 獲体 5は、電気的結合 (静電的相互作用)を介して、各核酸群 3から発現されるいず れの融合タンパク質をも捕獲することができる。 [0082] As the protein trap 5, a positively charged body or a negatively charged body may be used. Protein negatively charged at higher pH isoelectric point, since positively charged at low P H than the isoelectric point, by using a positive charge, or negatively charged body as protein capture body 5, the protein capturing The prey 5 can capture any fusion protein expressed from each nucleic acid group 3 via electrical coupling (electrostatic interaction).
[0083] 正電荷体及び負電荷体としては、例えば、正荷電基 (例えば、アミノ基、グァ -ジル 基、イミダゾール基)を有する物質、負荷電基 (例えば、カルボキシル基、スルホニル 基、リン酸基)を有する物質等が挙げられる。 [0083] As the positively charged body and the negatively charged body, for example, a positively charged group (for example, an amino group, guazyl) And a substance having a negatively charged group (for example, a carboxyl group, a sulfonyl group, or a phosphate group).
[0084] タンパク質捕獲体 5としては、アルキル基又はその誘導基、フエニル基又はその誘 導基等の疎水性基を有する物質を使用してもよい。タンパク質捕獲体 5として疎水性 基を有する物質を使用することにより、タンパク質捕獲体 5は、疎水性相互作用を介 して、各核酸群 3から発現される 、ずれの融合タンパク質をも捕獲することができる。 [0084] As the protein trap 5, a substance having a hydrophobic group such as an alkyl group or a derivative group thereof, a phenyl group or a derivative group thereof may be used. By using a substance having a hydrophobic group as the protein capturing body 5, the protein capturing body 5 can also capture a misaligned fusion protein expressed from each nucleic acid group 3 through a hydrophobic interaction. Can do.
[0085] タンパク質捕獲体 5として、正電荷体若しくは負電荷体、又は疎水性基を有する物 質を使用する場合、各核酸群 3から発現されるタンパク質が標的タンパク質とタグタン ノ ク質との融合タンパク質である力否かに関わらず、タンパク質捕獲体 5は各核酸群 3から発現される 、ずれのタンパク質をも捕獲することができるので、各核酸群 3から 発現されるタンパク質は、例えば、タグタンパク質と融合していない標的タンパク質、 タグタンパク質以外のタンパク質と融合した標的タンパク質等であってもよい。 [0085] When a positively charged body, a negatively charged body, or a substance having a hydrophobic group is used as the protein capture body 5, the protein expressed from each nucleic acid group 3 is a fusion of the target protein and the tag protein. Regardless of whether it is a protein or not, the protein capture body 5 is expressed from each nucleic acid group 3 and can also capture a misaligned protein. Therefore, the protein expressed from each nucleic acid group 3 is, for example, a tag It may be a target protein that is not fused with a protein, a target protein that is fused with a protein other than a tag protein, or the like.
[0086] タンパク質捕獲体 5は、隣接するタンパク質捕獲体間の距離が、互いに離反して存 在する複数の部分領域のうち隣接する部分領域間の距離よりも圧倒的に小さくなるよ うな密度で固体支持体 4の所定表面領域に固定されている。隣接するタンパク質捕 獲体間の距離は、互いに離反して存在する複数の部分領域のうち隣接する部分領 域間の距離の 100分の 1以下となるような密度で、固体支持体 4の所定表面領域に 固定されていることが好ましい。隣接するタンパク質捕獲体間の距離は、互いに離反 して存在する複数の部分領域のうち隣接する部分領域間の距離の 100分の 1以下、 1000分の 1以下、 1万分の 1以下、 10万分の 1以下、 100万分の 1以下、 1000万分 の 1以下と!/、うように、小さくなればなるほど好ま 、。 [0086] The protein capture body 5 has a density such that the distance between adjacent protein capture bodies is much smaller than the distance between adjacent partial areas among a plurality of partial areas that are separated from each other. The solid support 4 is fixed to a predetermined surface area. The distance between adjacent protein catchers is a density that is not more than 1/100 of the distance between adjacent partial areas among a plurality of partial areas that are separated from each other. It is preferably fixed to the surface region. The distance between adjacent protein capture bodies is less than 1/100, less than 1/1000, less than 1 / 10,000, and less than 100,000 minutes of the distance between adjacent partial areas among multiple partial areas that are separated from each other. 1 / less, 1 / 1,000,000 or less, 1 / 1,000,000 or less! /, The smaller, the better.
[0087] 図 1に示すように、固体支持体 4が固体支持体 2に螺旋状に卷装されて!/、る。 [0087] As shown in FIG. 1, the solid support 4 is spirally mounted on the solid support 2!
[0088] 固体支持体 4は、複数の核酸群 3が固定された固体支持体 2の所定表面領域 (核 酸固定表面領域)と複数のタンパク質捕獲体 5が固定された固体支持体 4の所定表 面領域 (タンパク質捕獲体固定表面領域)との距離が、互いに離反して存在する複 数の部分領域のうち隣接する部分領域間の距離よりも圧倒的に小さくなるように、固 体支持体 2に対して卷装されている。核酸固定表面領域とタンパク質捕獲体固定表 面領域との距離は、互いに離反して存在する複数の部分領域のうち隣接する部分領 域間の距離の 5分の 1以下であることが好ましい。核酸固定表面領域とタンパク質捕 獲体固定表面領域との距離は、互いに離反して存在する複数の部分領域のうち隣 接する部分領域間の距離の 5分の 1以下、 50分の 1以下、 500分の 1以下、 5000分 の 1以下というように、小さくなればなるほど好ましい。なお、タンパク質捕獲体固定表 面領域と核酸固定表面領域との距離の下限値は 0である。 [0088] The solid support 4 includes a predetermined surface region (nucleic acid fixation surface region) of the solid support 2 to which a plurality of nucleic acid groups 3 are fixed and a predetermined support of the solid support 4 to which a plurality of protein capture bodies 5 are fixed. The solid support so that the distance to the surface area (surface area on which the protein capturer is fixed) is overwhelmingly smaller than the distance between adjacent partial areas among a plurality of partial areas that are separated from each other. 2 are outfitted. The distance between the nucleic acid immobilization surface area and the protein capturer immobilization surface area is the distance between the adjacent partial areas of the plurality of partial areas that are separated from each other. It is preferable to be less than one fifth of the distance between the zones. The distance between the nucleic acid-immobilized surface region and the protein catcher-immobilized surface region is less than one fifth, less than one-fifth, and less than one-fifth of the distance between adjacent partial regions among a plurality of partial regions that are separated from each other The smaller it is, such as 1 / min or 1/5000 min or less, the better. Note that the lower limit of the distance between the protein capturer fixed surface region and the nucleic acid fixed surface region is zero.
[0089] 巻き軸方向単位長さあたりの固体支持体 4の巻き数は、タンパク質捕獲体固定表面 領域が各核酸群 3に近接する限り特に限定されるものではないが、複数の部分領域 の巻き軸方向の長さのうち、最も短い長さを巻き軸方向単位長さとしたときに、巻き軸 方向単位長さあたりの固体支持体 4の巻き数は、好ましくは 1回 Zmm以上、さらに好 ましくは 2回 Zmm以上である。巻き軸方向単位長さあたりの固体支持体 4の巻き数 の上限値は特に限定されるものではなぐ固体支持体 4の幅に応じて適宜調節する ことができる。各部分領域の巻き軸方向の長さは特に限定されるものではないが、通 常 0. 05mm以上、好ましくは 2mm以上である。各部分領域の巻き軸方向の長さの 上限値は特に限定されるものではなぐ第 1の固体支持体の大きさ等に応じて適宜 調節することができる力 通常 10mmである。固体支持体 4の幅は巻き軸方向単位長 さ以下であり、固体支持体 4は、タンパク質固定表面領域のうち異なる領域同士が重 ならないように第 1の固体支持体に卷装されている。なお、「巻き軸」とは、固体支持 体 2に卷装された固体支持体 4によって形成される螺旋の中心を通る線を意味する。 [0089] The number of windings of the solid support 4 per unit length in the winding axis direction is not particularly limited as long as the protein capturer fixing surface region is close to each nucleic acid group 3, but the winding of a plurality of partial regions is not limited. When the shortest length in the axial direction is taken as the unit length in the winding axis direction, the number of windings of the solid support 4 per unit length in the winding axis direction is preferably 1 mm or more, more preferably 2 times Zmm or more. The upper limit value of the number of turns of the solid support 4 per unit length in the winding axis direction is not particularly limited and can be appropriately adjusted according to the width of the solid support 4. The length of each partial region in the winding axis direction is not particularly limited, but is usually 0.05 mm or more, preferably 2 mm or more. The upper limit value of the length of each partial region in the winding axis direction is not particularly limited, and is a force that can be appropriately adjusted according to the size of the first solid support and the like, which is usually 10 mm. The width of the solid support 4 is equal to or less than the unit length in the winding axis direction, and the solid support 4 is mounted on the first solid support so that different regions of the protein-immobilized surface region do not overlap each other. The “winding axis” means a line passing through the center of a spiral formed by the solid support 4 mounted on the solid support 2.
[0090] 複数の部分領域の巻き軸方向の長さのうち、最も短い長さを巻き軸方向単位長さと したときに、巻き軸方向単位長さあたりの固体支持体 4の巻き数が 1回 Zmm以上で あると、タンパク質捕獲体固定表面領域のうち異なる領域が各核酸群 3に近接するの で、各核酸群 3から発現されたタンパク質のクロスコンタミネーシヨンを効果的に防止 することができる。 [0090] Among the lengths of the plurality of partial regions in the winding axis direction, when the shortest length is taken as the winding axis direction unit length, the number of windings of the solid support 4 per winding axis direction unit length is 1 If it is Zmm or more, a different region of the protein trap body fixing surface region is close to each nucleic acid group 3, so that cross-contamination of proteins expressed from each nucleic acid group 3 can be effectively prevented. .
[0091] 核酸ライブラリー 1において、タンパク質捕獲体 5は、核酸群 3が固定された固体支 持体 2の所定表面領域に近接して高密度に配列しているので、各核酸群 3には、核 酸群 3ごとに異なるタンパク質捕獲体 5が近接している。また、各核酸群 3は互いに離 反した状態で固体支持体 2の表面に固定されているので、一の核酸群 3と一の核酸 群 3に近接するタンパク質捕獲体 5との距離は、他の核酸群 3と一の核酸群 3に近接 するタンパク質捕獲体 5との距離よりも圧倒的に小さくなつている。したがって、核酸ラ イブラリー 1を in vitro転写 ·翻訳系又は in vitro翻訳系に供して、核酸ライブラリーに 含まれる複数の核酸群 3を一度に発現させると、各核酸群 3から発現されたタンパク 質は、各核酸群 3に近接するタンパク質捕獲体 5に優先的に捕獲されるので、各核 酸群 3から発現されたタンパク質のクロスコンタミネーシヨンは防止される。特に核酸ラ イブラリー 1においては、核酸群 3間に介在する固体支持体 4が障壁となり、各核酸 群 3から発現されたタンパク質のクロスコンタミネーシヨンは効果的に防止される。 [0091] In the nucleic acid library 1, the protein capturing bodies 5 are arranged at high density close to the predetermined surface region of the solid support 2 to which the nucleic acid groups 3 are fixed. Different protein capture bodies 5 are close to each other in each of the nuclear acid groups 3. Further, since each nucleic acid group 3 is fixed to the surface of the solid support 2 in a state of being separated from each other, the distance between one nucleic acid group 3 and the protein capture body 5 adjacent to one nucleic acid group 3 is different from the other. In close proximity to one nucleic acid group 3 and one nucleic acid group 3 It is overwhelmingly smaller than the distance to the protein capture body 5 to be. Therefore, if the nucleic acid library 1 is subjected to an in vitro transcription / translation system or an in vitro translation system and a plurality of nucleic acid groups 3 contained in the nucleic acid library are expressed at once, the proteins expressed from each nucleic acid group 3 are expressed. Is preferentially captured by the protein capturing body 5 adjacent to each nucleic acid group 3, so that cross-contamination of the protein expressed from each nucleic acid group 3 is prevented. Particularly in the nucleic acid library 1, the solid support 4 interposed between the nucleic acid groups 3 serves as a barrier, and cross-contamination of proteins expressed from the nucleic acid groups 3 is effectively prevented.
[0092] すなわち、核酸ライブラリー 1を in vitro転写 ·翻訳系又は in vitro翻訳系に供して、 核酸ライブラリー 1に含まれる複数の核酸群 3を一度に発現させることにより、各核酸 群 3から発現された複数種類のタンパク質が、それをコードする核酸と対応付けた状 態で固体支持体 4上にディスプレイされたタンパク質ライブラリーを作製することがで きる。このとき、一度に発現させる核酸群 3は 2種類以上である限り、核酸ライブラリー 1が有する全ての核酸群 3であってもよいし、核酸ライブラリー 1が有する一部の核酸 群 3であってもよい。 [0092] That is, by subjecting the nucleic acid library 1 to an in vitro transcription / translation system or an in vitro translation system to express a plurality of nucleic acid groups 3 contained in the nucleic acid library 1 at a time, A protein library in which a plurality of types of expressed proteins are displayed on the solid support 4 in a state in which they are associated with the nucleic acid encoding them can be prepared. At this time, as long as there are two or more types of nucleic acid groups 3 to be expressed at one time, all of the nucleic acid groups 3 included in the nucleic acid library 1 may be used, or some of the nucleic acid groups 3 included in the nucleic acid library 1 may be included. May be.
[0093] 核酸ライブラリー 1は in vitro転写 ·翻訳系又は in vitro翻訳系に供すると直ちにタン ノ ク質ライブラリーに変換されるので、タンパク質の供給とタンパク質のアツセィ系とが 一体となっており、複数種類のタンパク質の供給後、直ちに当該複数種類のタンパク 質解析を開始することができる。 [0093] Nucleic acid library 1 is immediately converted into a protein library when subjected to an in vitro transcription / translation system or in vitro translation system, so the protein supply and protein assembly system are integrated. The analysis of the plurality of types of proteins can be started immediately after the supply of the plurality of types of proteins.
[0094] 核酸ライブラリー 1から作製されたタンパク質ライブラリーにおいては、固体支持体 4 が固体支持体 2に卷装された状態のままでも、固体支持体 4上にディスプレイされた タンパク質へのアクセスが容易であるので、タンパク質ライブラリーの作製力 タンパ ク質ライブラリーを利用したタンパク質の解析に至る一連の操作の自動化を容易に図 ることがでさる。 [0094] In the protein library prepared from the nucleic acid library 1, the protein displayed on the solid support 4 can be accessed even when the solid support 4 is mounted on the solid support 2. Since it is easy, it is possible to easily automate a series of operations up to protein analysis using a protein library.
[0095] 核酸ライブラリー 1から作製されたタンパク質ライブラリーにおいて、タンパク質ライ ブラリーに含まれるタンパク質が、タンパク質解析途中に変性や失活を起こしたとして も、そのタンパク質をコードする核酸を再度発現させることにより、そのタンパク質の再 生が可能である。 [0095] In the protein library prepared from the nucleic acid library 1, even if the protein contained in the protein library is denatured or inactivated during the protein analysis, the nucleic acid encoding the protein is expressed again. Thus, the protein can be regenerated.
[0096] タンパク質解析の終了後は、次回使用するときまで核酸ライブラリー 1の状態で保 存しておき、必要なときにタンパク質ライブラリーを再生させることにより、長期間にわ たり繰り返し使用することができる。 [0096] After the protein analysis is completed, the nucleic acid library 1 is maintained until the next use. It can be used repeatedly over a long period of time by regenerating the protein library when necessary.
[0097] 核酸ライブラリー 1は、固体支持体 2の所定表面領域のうち互いに離反して存在す る複数の部位領域に、それぞれ、複数の核酸群 3のうち一の核酸群を固定し、固体 支持体 4の所定表面領域に、複数のタンパク質捕獲体 5を高密度で固定し、複数の タンパク質捕獲体 5が固定された所定表面領域が、複数の核酸群 3が固定された所 定表面領域に近接するように、固体支持体 2に対して固体支持体 4を卷装することに より作製することができる。 [0097] The nucleic acid library 1 is obtained by fixing one nucleic acid group of a plurality of nucleic acid groups 3 to a plurality of site regions that are separated from each other in a predetermined surface region of the solid support 2, and A plurality of protein capture bodies 5 are fixed at a high density to a predetermined surface area of the support 4, and a predetermined surface area where a plurality of protein capture bodies 5 are fixed is a predetermined surface area where a plurality of nucleic acid groups 3 are fixed. The solid support 4 can be manufactured by mounting the solid support 4 on the solid support 2 so as to be close to the substrate.
[0098] 固体支持体の表面への核酸又はタンパク質捕獲体の固定方法は特に限定される ものではなぐ例えば、特定物質間の特異的相互作用、共有結合 (例えば、アミド結 合、ジスルフイド結合、チォエーテル結合)の形成等を利用することができる。 [0098] The method for immobilizing a nucleic acid or protein trap on the surface of a solid support is not particularly limited. For example, specific interactions between specific substances, covalent bonds (for example, amide bonds, disulfide bonds, thioethers). (Bond) formation or the like can be used.
[0099] 特定物質間の特異的相互作用としては、例えば、アビジン又はその誘導体 (例えば 、ストレプトアビジン、ェクストラアビジン(ExtraAvidin)、ニュートロアビジン(NeutrAvid in) )Zピオチン又はその誘導体 (例えば、イミノビォチン、カルボピオチン、ピオチン ヒドラジド);マルトース結合タンパク質 Zマルトース;ポリヒスチジンペプチド ッケ ル、コバルト等の金属イオン;グルタチオン S トランスフェラーゼ Zグルタチオン; カルモジュリン Zカルモジュリン結合ペプチド; ATP結合タンパク質 ZATP;核酸 Z 相補的核酸;受容体タンパク質 Zリガンド;酵素 Z基質;抗体 Z抗原; IgGZプロティ ン A又は G等の特異的相互作用を利用することができる。特異的相互作用を生じる 物質は常法に従って核酸、タンパク質捕獲体又は固体支持体に結合させることがで きる。 [0099] Specific interactions between specific substances include, for example, avidin or a derivative thereof (eg, streptavidin, extraavidin, NeutrAvidin) Z piotin or a derivative thereof (eg, iminobiotin) Maltose binding protein Z maltose; metal ions such as polyhistidine peptide nickel and cobalt; glutathione S transferase Z glutathione; calmodulin Z calmodulin binding peptide; ATP binding protein ZATP; nucleic acid Z complementary nucleic acid; Specific interactions such as body protein Z ligand; enzyme Z substrate; antibody Z antigen; IgGZ protein A or G can be used. Substances that produce specific interactions can be bound to nucleic acids, protein capture bodies or solid supports according to conventional methods.
[0100] 共有結合は、核酸群 3に含まれる核酸又はタンパク質捕獲体 5が有する官能基 (核 酸又はタンパク質捕獲体に人為的に導入された官能基を含む。)と、固体支持体 2又 は 4が有する官能基(固体支持体 2又は 4に人為的に導入された官能基を含む。)と を反応させることにより形成させることができる。共有結合を形成する官能基としては 、例えば、カルボキシル基、アミノ基、水酸基、スルフヒドリル基、アルデヒド基等が挙 げられる。 [0100] The covalent bond includes a functional group (including a functional group artificially introduced into the nucleic acid or protein capture body) of the nucleic acid or protein capture body 5 included in the nucleic acid group 3, and the solid support 2 or Can be formed by reacting with a functional group possessed by 4 (including a functional group artificially introduced into the solid support 2 or 4). Examples of the functional group that forms a covalent bond include a carboxyl group, an amino group, a hydroxyl group, a sulfhydryl group, and an aldehyde group.
[0101] 共有結合の形成には、架橋剤を利用することができる。架橋剤としては、例えば、 N —スクシンィミジル (4—ィオードァセチル)ァミノべンゾエート(N— succinimidyl(4— iodoacet yDaminobenzoate) (SIAB)、ジマレイミド(dimaleimide)、ジチォ-ビス -ニトロ安息香酸( dithio-bis-nitrobenzoic acid) (DTNB)、 N-スクシンィミジル- S-ァセチル-チオアセテ ート(N-succinimidyl-S- acetyl- thioacetate) (SATA)、 N-スクシンィミジル- 3- (2-ピリジ ルジチォ)プロピオネート(N- succinimidyl- 3- (2- pyridyldithio)propionate) (SPDP)、ス クシンィミジル 4-(N-マレイミドメチル)シクロへキサン- 1-カルボキシレート(succinimid yl 4-(N-maleimidomethyl)cyclohexane- 1 -carboxylate) (SMCC)、 6—ヒドラジノニコチミ ド(6- hydrazinonicotimide) (HYNIC)、 m—マレイミドベンゾィル N ヒドロキシスク 、ノニ rエスアル (m-maleimidobenzoyl-N-hydroxysuccinimide ester) (MBし)等の多 官能性試薬が挙げられる。 [0101] A crosslinking agent can be used for the formation of the covalent bond. Examples of cross-linking agents include N —Succinimidyl (4—iodoacetyl) aminobenzoate (SIAB), dimaleimide, dithio-bis-nitrobenzoic acid (DTNB), N- N-succinimidyl-S-acetyl-thioacetate (SATA), N-succinimidyl-3- (2-pyridyldithio) propionate ) (SPDP), succinimidyl 4- (N-maleimidomethyl) cyclohexane-1-carboxylate (SMCC), 6-hydrazinonicotimide And polyfunctional reagents such as (6-hydrazinonicotimide) (HYNIC), m-maleimidobenzoyl-N-hydroxysuccinimide ester (MB), and the like.
[0102] 固体支持体 2の表面への核酸を固定する際に、特定物質 (物質 A及び B)間の特異 的相互作用を利用する場合、例えば、固体支持体表面の所定の部位領域に物質 A を固定し、物質 Bを結合させた核酸を含有する溶液を所定の部位領域にスポットする 。この際、固体支持体 2の材質が、核酸溶液が浸透可能な材質であると、隣接する部 位領域にスポットされた核酸溶液間でコンタミネーシヨンが生じるおそれがある。そこ で、固体支持体 2の材質が、核酸溶液が浸透可能な材質である場合には、核酸溶液 力 Sスポットされる部位領域のうち隣接する部位領域の間に、核酸の通過を防止するこ とができる物質を含有する溶液を予めスポットしておくことが好ま 、。このような溶液 を予めスポットしておくことにより、固体支持体 2の内部に障壁が形成され、隣接する 部位領域にスポットされた核酸溶液間でコンタミネーシヨンが生じることを防止するこ とができる。核酸の通過を防止することができる物質としては、例えば、カゼイン、スキ ムミルク、ゼラチン、 BSA等のタンパク質性物質、グルコース、ショ糖、ラフイノース、 デキストリン、スターチ等の糖類、デキストランサルフェート、 PVP、グリセリン、 PEG等 の粘性物質、固体支持体 2から遊離した物質 A等が挙げられる。 [0102] When a specific interaction between specific substances (substances A and B) is used when immobilizing nucleic acids on the surface of the solid support 2, for example, a substance is placed in a predetermined region of the surface of the solid support. A solution containing nucleic acid to which A is fixed and substance B is bound is spotted on a predetermined region. In this case, if the material of the solid support 2 is a material that can penetrate the nucleic acid solution, contamination may occur between the nucleic acid solutions spotted on the adjacent region. Therefore, when the material of the solid support 2 is a material that can be penetrated by the nucleic acid solution, the nucleic acid solution force S prevents the nucleic acid from passing between the adjacent site regions. It is preferable to spot in advance a solution containing a substance that can be used. By pre-spotting such a solution, a barrier is formed inside the solid support 2 and it is possible to prevent contamination from occurring between the nucleic acid solutions spotted in the adjacent site regions. . Examples of substances that can prevent the passage of nucleic acids include protein substances such as casein, skim milk, gelatin, and BSA, sugars such as glucose, sucrose, raffinose, dextrin, and starch, dextran sulfate, PVP, glycerin, Examples include viscous substances such as PEG and substances A released from the solid support 2.
[0103] また、核酸溶液がスポットされる部位領域のうち、隣接する部位領域の間に、カゼィ ン、スキムミルク、ゼラチン、 BSA等のタンパク質性物質、各核酸群 3から発現される 融合タンパク質に含まれるタグタンパク質に結合することができるタンパク質捕獲体 等を含有する溶液を予めスポットしておくことにより、各核酸群 3から発現されたタンパ ク質が固体支持体 2に非特異的に吸着することを防止することができる。 [0103] Among the site regions where the nucleic acid solution is spotted, between adjacent site regions, proteinaceous substances such as casein, skim milk, gelatin, BSA, and fusion proteins expressed from each nucleic acid group 3 are included. By pre-spotting a solution containing a protein trap that can bind to the tag protein to be expressed, the tamper expressed from each nucleic acid group 3 It is possible to prevent the soil from adsorbing to the solid support 2 nonspecifically.
[0104] 固体支持体 2に対して固体支持体 4を卷装する際、タンパク質捕獲体 5が固定され た固体支持体 2の所定表面領域を、核酸群 3が固定された固体支持体 4の所定表面 領域に近接させればよい。すなわち、タンパク質捕獲体 5を核酸群 3の位置と対応付 けて配列させる必要はなぐ核酸群 3の位置に関係なくランダムに配列させればょ 、 。したがって、核酸ライブラリー 1は効率的に作製することができる。 [0104] When the solid support 4 is mounted on the solid support 2, the predetermined surface area of the solid support 2 to which the protein capturing body 5 is fixed is changed to the predetermined surface area of the solid support 4 to which the nucleic acid group 3 is fixed. What is necessary is just to make it adjoin to a predetermined surface area | region. In other words, it is not necessary to arrange the protein capturing body 5 in correspondence with the position of the nucleic acid group 3; Therefore, the nucleic acid library 1 can be produced efficiently.
実施例 Example
[0105] 〔実施例 1〕 [Example 1]
実施例 1は、铸型 DNA固定ィ匕ナイロン糸と、該ナイロン糸に巻き付けたニッケルキレ ート固定ィ匕綿糸とからなる複合糸を in vitro転写 ·翻訳系に供し、铸型 DNAから発現し た Hisタグ標識タンパク質をニッケルキレート固定ィ匕綿糸上に固定ィ匕した実施例であ In Example 1, a composite yarn composed of a cage DNA-immobilized nylon yarn and a nickel chelate-immobilized cotton yarn wound around the nylon yarn was subjected to an in vitro transcription / translation system and expressed from the cage DNA. In this example, a His-tagged protein was immobilized on a nickel chelate immobilized cotton thread.
6 6
る。 The
[0106] 1.ニッケルキレート固定化綿糸の作製 [0106] 1. Fabrication of nickel chelate-immobilized cotton yarn
(1)綿糸の活性ィ匕 (1) Cotton yarn activity
30cmに切断した 60番綿糸(直径:約 0.2mm)を 6本用意し、蒸留水中でオートクレー ブにより滅菌(120°C, 15分間)した後、 30%アセトン 3mlで 3回洗浄した。以下の反応 は特記しない限り 4°Cで行った。 70%アセトン 3mlで 3回の洗浄、 100%アセトン 3mlで 3 回の洗浄、無水アセトン 3mlで 3回の洗浄、及び無水ァセトニトリル 3mlで 3回の洗浄を 行った後、 0.33M p--トロフエ-ルクロロフオルマート Z無水ァセトニトリルを 2mlカロえ 、次いで、 1.0Mジメチルァミノピリジン Z無水ァセトニトリルを 2mlカ卩え、 1時間放置し た。その後、 100%アセトン 3mlで 3回の洗浄、 5%酢酸 Zジォキサン 3mlで 3回の洗浄、 メタノール 3mlで 3回の洗浄、及び無水 2-プロパノール 3mlで 3回の洗浄を行い、無水 2 -プロパノール中、 4°Cで使用するまで保存した。 Six 60th cotton yarns (diameter: about 0.2mm) cut to 30cm were prepared, sterilized in distilled water by autoclave (120 ° C, 15 minutes), and then washed 3 times with 3ml of 30% acetone. The following reactions were performed at 4 ° C unless otherwise stated. After washing 3 times with 3 ml of 70% acetone, 3 times with 3 ml of 100% acetone, 3 times with 3 ml of anhydrous acetone, and 3 times with 3 ml of anhydrous acetonitrile, 0.33M p--Trophe- 2 ml of chloroformate Z anhydrous acetonitrile was added and then 2 ml of 1.0M dimethylaminopyridine Z anhydrous acetonitrile was added and allowed to stand for 1 hour. Then wash 3 times with 3 ml of 100% acetone, 3 times with 3 ml of 5% acetic acid Z-dioxane, 3 times with 3 ml of methanol, and 3 times with 3 ml of anhydrous 2-propanol. Medium and stored at 4 ° C until use.
[0107] (2)ニッケルキレートイ匕 [0107] (2) Nickel chelate
活性ィ匕した糸を 3本用意し、蒸留水 3mlで 3回洗浄 (4°C)した後、 10mg/mlの AB-NT A/0.1Mリン酸ナトリウム緩衝液 (pH 7.4)を lmlカ卩え、室温で 48時間反応させた。その 後、 0.1Mリン酸緩衝液(pH 7.5) 3mlで 3回洗浄し、 0.1Mモノエタノールァミン(pH 7.5 ) 50mlを加え、室温で 24時間反応させた。その後、 0.1Mリン酸緩衝液 (pH 7.5) 3mlで 3回洗浄し、 0.1Mモノエタノールァミン(pH 7.5) 50mlをカ卩え、室温で 24時間反応させ た。その後、 0.1Mリン酸緩衝液 (pH 7.5) 3mlで 3回洗浄し、 1%酢酸ニッケル水溶液に 室温で 2時間浸漬し、蒸留水 3mlで 3回洗浄した。 Prepare three activated yarns, wash them with 3 ml of distilled water 3 times (4 ° C), and then add 10 mg / ml AB-NT A / 0.1M sodium phosphate buffer (pH 7.4) to 1 ml. The reaction was allowed to proceed for 48 hours at room temperature. Thereafter, the plate was washed 3 times with 3 ml of 0.1 M phosphate buffer (pH 7.5), 50 ml of 0.1 M monoethanolamine (pH 7.5) was added, and the mixture was reacted at room temperature for 24 hours. Then add 3 ml of 0.1M phosphate buffer (pH 7.5) After washing 3 times, 50 ml of 0.1M monoethanolamine (pH 7.5) was added and reacted at room temperature for 24 hours. Thereafter, it was washed 3 times with 3 ml of 0.1M phosphate buffer (pH 7.5), immersed in a 1% nickel acetate aqueous solution for 2 hours at room temperature, and washed 3 times with 3 ml of distilled water.
[0108] 以上のようにして、ニッケルキレートが表面に高密度で固定された綿糸を作製した。 [0108] As described above, a cotton yarn having a nickel chelate fixed on the surface thereof at high density was produced.
綿糸に固定された多量のニッケルキレートのうち、隣接するニッケルキレート間の距 離は約 2〜20nm (推測値)と予想される。なお、後述するように、ナイロン糸に固定さ れた複数の铸型 DNA群のうち、隣接する铸型 DNA群間の距離は約 5mmであるので、 隣接するニッケルキレート間の距離は、隣接する铸型 DNA群間の距離の約 250万分 の 1 (約 0.000004倍)となっており、隣接するニッケルキレート間の距離は、隣接する铸 型 DNA群間の距離よりも圧倒的に小さくなつている。 Of the large amount of nickel chelate fixed to cotton yarn, the distance between adjacent nickel chelates is expected to be about 2 to 20 nm (estimated value). As will be described later, among the plurality of saddle DNA groups fixed to the nylon thread, the distance between adjacent saddle DNA groups is about 5 mm, so the distance between adjacent nickel chelates is adjacent. The distance between adjacent DNA groups is 1 / 2.5 million (about 0.000004 times), and the distance between adjacent nickel chelates is far smaller than the distance between adjacent DNA groups. .
[0109] 2.铸型 DNA固定化ナイロン糸の作製 [0109] 2. Fabrication of saddle-shaped DNA-immobilized nylon thread
(1)铸型 DNAの調製 (1) Preparation of vertical DNA
ストレプトアビジン遺伝子の 5'末側に Hisタグ(6個のヒスチジンからなるタグタンパク His tag (tag protein consisting of 6 histidines) at the 5 'end of the streptavidin gene
6 6
質)コード配列を連結し、さらに、 5'末端に T7プロモーター配列及びリボソーム結合配 列(RBS)を、 3'末端に T7配列をそれぞれ付カ卩し、プラスミドベクター(pGEM-Teasy) にクロー-ングし、 His -アビジン融合タンパク質をコードする铸型 DNA (以下「His -ァ The coding sequence is ligated, and the T7 promoter sequence and ribosome binding sequence (RBS) are attached to the 5 'end, and the T7 sequence is attached to the 3' end.铸 DNA encoding His-avidin fusion protein (hereinafter referred to as “His-a”)
6 6 ビジン铸型 DNA」と ヽぅ。 )を作製した (配列番号 3参照)。 6 6 “Vidin-type DNA”. (See SEQ ID NO: 3).
[0110] GFP(green fluorescent protein)- Hisをコードする铸型 DNA (以下「GFP- His铸型 D [0110] GFP (green fluorescent protein) -His-encoded DNA (hereinafter “GFP-His-type D”)
6 6 6 6
NA」という。)は、 Rapid Translation System (ロシュ)用コントロールプラスミド pIVEX co ntrol vector GFPを用いて作製した(配列番号 4参照)。このプラスミドは、 GFPの C末 端側に Hisタグが融合されたタンパク質を発現する構造を有している。 NA ". ) Was prepared using the Rapid Translation System (Roche) control plasmid pIVEX control vector GFP (see SEQ ID NO: 4). This plasmid has a structure expressing a protein in which a His tag is fused to the C-terminal side of GFP.
6 6
[0111] GST(glutathione s- transferase)- Hisをコードする铸型 DNA (以下「GST- His铸型 D [0111] STDNA encoding GST (glutathione s-transferase) -His (hereinafter referred to as “GST-His D D”
6 6 6 6
NA」という。)は、ロシュ社製の Linear template generation set, His- tagを用いて GST 遺伝子の 3'末端側に Hisタグコード配列を融合することにより作製した (配列番号 5参 NA ". ) Was prepared by fusing the His tag coding sequence to the 3 'end of the GST gene using a Roche Linear template generation set, His-tag (see SEQ ID NO: 5).
6 6
照)。 See).
[0112] 各铸型 DNAの構造の模式図を図 2に示す。 [0112] Figure 2 shows a schematic diagram of the structure of each cage DNA.
各铸型 DNAを铸型として、 PCRにより各铸型 DNAの増幅と 5'末端側へのジゴキシゲ ニン (DIG)配列の付加を行った。 PCR反応液の組成及び反応条件は以下の通りであ る。 PCR反応液の組成は、 10ng/ μ 1 DNA 4.0 μ \, 20 μ Μ forward primer (DIG- 17f, 配列番号 1参照) 8.0 μ 20 μ Μ reverse primer (l lr,配列番号 2参照) 8.0 1、 10 X Ex Taq緩衝液 20 μ 1、 2.5mM dNTPs 20 μ 1、 LA Taq (5U/ μ 1) 2.0 1、 dH O 138 1 ( Using each cage DNA as a cage, amplification of each cage DNA by PCR and addition of a digoxigenin (DIG) sequence to the 5 ′ end side were performed. The composition and reaction conditions of the PCR reaction solution are as follows: The The composition of the PCR reaction solution is 10 ng / μ 1 DNA 4.0 μ \, 20 μ Μ forward primer (DIG-17f, see SEQ ID NO: 1) 8.0 μ 20 μ Μ reverse primer (see l lr, SEQ ID NO: 2) 8.0 1, 10 X Ex Taq buffer 20 μ 1, 2.5 mM dNTPs 20 μ 1, LA Taq (5U / μ 1) 2.0 1, dH O 138 1 (
2 総量 200 μ 1)である。反応条件は、(0 94°Cで 1分間、(ii) 94°Cで 1分間、 94°Cで 30秒間 、 55°Cで 30秒間及び 72°Cで 1分間の反応サイクルを 30サイクルであり、 PCR産物は使 用するまで 4°Cで保存した。 2 The total amount is 200 μ 1). The reaction conditions were (0 94 ° C for 1 minute, (ii) 94 ° C for 1 minute, 94 ° C for 30 seconds, 55 ° C for 30 seconds and 72 ° C for 1 minute for 30 cycles. Yes, PCR products were stored at 4 ° C until use.
[0113] (2)铸型 DNAの精製 [0113] (2) Purification of vertical DNA
MicroSpin S- 400 HRカラムを用い、 100 μ 1ずつゲル濾過精製を行った。次いで、 7. 5Μ酢酸アンモ-ゥムを 60 μ 1加え、 EtoHを 500 μ 1加え、 - 80°Cで 20分間放置し、 4°C、 15000rpmで 15分間遠心し、上清を捨てた。次いで、 70% EtoHを 800 1カ卩え、 4°C、 15 OOOrpmで 5分間遠心し、上清を捨て、減圧下で乾燥した。使用する際には、 1の T Eで溶解した。 Using a MicroSpin S-400 HR column, gel filtration purification was performed 100 μl at a time. Next, 60 μl of 7.5% ammonium acetate was added, 500 μl of EtoH was added, left at −80 ° C. for 20 minutes, centrifuged at 4 ° C. and 15000 rpm for 15 minutes, and the supernatant was discarded. Next, 800 1 of 70% EtoH was added, centrifuged at 4 ° C, 15 OOOrpm for 5 minutes, the supernatant was discarded and dried under reduced pressure. When used, it was dissolved in 1 TE.
[0114] (3)ナイロン糸への铸型 DNAの固定化 [0114] (3) Immobilization of saddle DNA on nylon thread
ナイロン糸としては、表面を 4〜6Nの塩酸で処理し(20〜25°C, 0.5〜15秒)、表面 を多孔質ィ匕したものを使用した。ナイロン糸に 5mm間隔にて 200 g/mlの抗 DIG抗体 (ロシュ) 0.4 1をスポットし、室温で 40分間乾燥させた。抗体をスポットした上に、精製 した DIG標識铸型 DNAを 0.4 1スポットし、室温で 90分間乾燥させた。 As the nylon thread, the surface was treated with 4-6N hydrochloric acid (20-25 ° C, 0.5-15 seconds) and the surface was made porous. 200 g / ml anti-DIG antibody (Roche) 0.41 was spotted on nylon thread at intervals of 5 mm and dried at room temperature for 40 minutes. On the spotted antibody, 0.41 spot of purified DIG-labeled vertical DNA was spotted and dried at room temperature for 90 minutes.
以上のようにして、複数の铸型 DNA群(1つのスポットが 1つの铸型 DNA群に対応す る)が表面に固定されたナイロン糸を作製した。 As described above, a nylon thread having a plurality of cage DNA groups (one spot corresponding to one cage DNA group) fixed on the surface was produced.
[0115] 3.複合糸の作製 [0115] 3. Preparation of composite yarn
ニッケルキレートが表面に高密度で固定された綿糸を、铸型 DNAが表面に固定さ れたナイロン糸に巻き付け、複合糸を作製した。このとき、綿糸の直径は 0.2mmである ので、ニッケルキレートが固定された綿糸表面と铸型 DNAが固定されたナイロン糸表 面との距離は、約 0〜0.2mmの範囲にある。綿糸の巻き数は、ナイロン糸 5mmあたり 3 回とした。 A cotton yarn with a nickel chelate fixed at a high density on the surface was wrapped around a nylon yarn with a hook-shaped DNA fixed on the surface to produce a composite yarn. At this time, since the diameter of the cotton yarn is 0.2 mm, the distance between the surface of the cotton yarn to which the nickel chelate is immobilized and the surface of the nylon yarn to which the cage DNA is immobilized is in the range of about 0 to 0.2 mm. Cotton yarn was wound three times per 5mm nylon yarn.
複合糸は、 1% SDS/lxSSCで洗浄し、 10mM Tris-HCl(pH7.5)で洗浄した後、使用し た。 The composite yarn was washed with 1% SDS / lxSSC, washed with 10 mM Tris-HCl (pH 7.5), and then used.
[0116] 4. in vitro転写'翻訳系によるタンパク質の発現 複合糸を 2本同様に作製し、ガラスキヤビラリ一中の Rapid Translation System (RTS) (ロシュ)反応液に入れ、 in vitro転写 ·翻訳系によりタンパク質を発現させた。反応液 はロシュ社のキット付属プロトコルに従って調製し、 30°Cで 2時間反応させた。 RTS反 応後の複合糸を洗浄した後、 peroxidase(POD)標識抗 His抗体及び抗 GFP抗体によ [0116] 4. In vitro transcription 'protein expression by translation system Two composite yarns were prepared in the same manner, and placed in the Rapid Translation System (RTS) reaction solution in the glass cabinet, and the protein was expressed by an in vitro transcription / translation system. The reaction solution was prepared according to the protocol attached to the Roche kit and reacted at 30 ° C for 2 hours. After washing the composite yarn after RTS reaction, peroxidase (POD) -labeled anti-His antibody and anti-GFP antibody are used.
6 6
る検出を行った。 Detection was performed.
[0117] (1)複合糸に固定化されたタンパク質の検出 (化学発光法) [0117] (1) Detection of protein immobilized on composite yarn (chemiluminescence method)
RTS反応後の複合糸を 20mMイミダゾール /PBS緩衝液で洗浄し、 0.5% blocking rea gent (ロシュ)に 30分間浸漬し、 PBS緩衝液で洗浄した。次いで、 PBSにて希釈した PO D(peroxidase)標識抗 His抗体、抗 GFP抗体及び抗 GST抗体に 30分間浸漬し、 PBS緩 The composite yarn after the RTS reaction was washed with 20 mM imidazole / PBS buffer, immersed in 0.5% blocking rea gent (Roche) for 30 minutes, and washed with PBS buffer. Then, immerse in POD (peroxidase) -labeled anti-His antibody, anti-GFP antibody, and anti-GST antibody diluted in PBS for 30 minutes, and relax with PBS.
6 6
衝液で洗浄した後、 ECL Detection Reagents (アマシャム) 10 μ 1を加え、 CCD撮景装 置 ARGUS (浜松ホトニタス)により発光を検出した。 After washing with the impulse solution, 10 µ 1 of ECL Detection Reagents (Amersham) was added, and luminescence was detected by CCD imaging device ARGUS (Hamamatsu Photonicus).
[0118] (2)複合糸に固定化されたタンパク質の検出 (蛍光法) [0118] (2) Detection of protein immobilized on composite yarn (fluorescence method)
上記(1)と同様に RTS反応を行った複合糸をほどいて綿糸のみを取り出し、綿糸に 固定ィ匕されたタンパク質を、蛍光標識抗体を用いて検出した。綿糸は、 20mMイミダ ゾール /PBSで洗浄し、 1% block ace/PBSに 30分間浸漬した後、 PBSで洗浄し、 1% bio ck ace/PBSにて 100倍希釈した抗 GFP抗体及び抗 GST抗体の混合液に 30分間浸漬 した。 PBSで洗浄した後、 2.5% block ace/PBSにて 100倍希釈した Cy5標識抗ゥサギ Ig G(H+L)抗体、 AF488標識抗ネズミ IgG(H+L)抗体に 30分間浸漬した。 PBSで洗浄した 後、蛍光スキャナ (STORM, FL595: ABI)で綿糸の蛍光を測定した。 As in (1) above, the composite yarn subjected to the RTS reaction was unwound and only the cotton yarn was taken out, and the protein immobilized on the cotton yarn was detected using a fluorescently labeled antibody. Cotton yarn is washed with 20 mM imidazole / PBS, soaked in 1% block ace / PBS for 30 minutes, washed with PBS, and diluted 100-fold with 1% bio ace ace / PBS. Anti-GFP antibody and anti-GST antibody Soaked for 30 minutes. After washing with PBS, the cells were immersed in Cy5-labeled anti-rabbit Ig G (H + L) antibody and AF488-labeled anti-murine IgG (H + L) antibody diluted 100-fold with 2.5% block ace / PBS for 30 minutes. After washing with PBS, the fluorescence of the cotton yarn was measured with a fluorescence scanner (STORM, FL595: ABI).
[0119] (3)結果 [0119] (3) Results
His -アビジン铸型 DNA又は GFP-His铸型 DNAを固定化した複合糸の模式図を図 Schematic diagram of a composite thread with immobilized His-avidin-type DNA or GFP-His-type DNA
6 6 6 6
3 (b)に示す。この複合糸において、図 3 (b)に示すように、 GFP- His铸型 DNA (スポ 3 As shown in (b). In this composite yarn, as shown in Fig. 3 (b), GFP-His 铸 DNA (spot
6 6
ット 1,3,5, 7,9)及び His -アビジン铸型 DNA (スポット 2,4,6,8)は、それぞれ 5ケ所及び 4 1, 3, 5, 7, 9) and His-avidin-type DNA (spots 2, 4, 6, 8), 5 and 4 respectively.
6 6
ケ所に交互にスポットされている。この複合糸に固定ィ匕されたタンパク質を抗 His抗 It is spotted alternately at the place. The protein immobilized on this composite yarn
6 体及び抗 GFP抗体を用いて検出した結果、図 3 (a)に示すように、抗 His抗体で検出 As a result of detection using 6 antibodies and anti-GFP antibody, detection with anti-His antibody was performed as shown in Fig. 3 (a).
6 6
した場合には 9ケ所のスポット (スポット 1〜9)が確認され、抗 GFP抗体で検出した場合 には 1ケ所おきに 5ケ所のスポット(スポット 1,3,5,7,9)が確認された。また各シグナルが 独立して検出されていることから、各スポット間でのタンパク質のコンタミネーシヨンは 無い又は非常に低いことが予測された。 9 spots (spots 1-9) were confirmed, and 5 spots (spots 1, 3, 5, 7, 9) were confirmed every other spot when detected with anti-GFP antibody. It was. Since each signal is detected independently, protein contamination between spots is None or very low was expected.
[0120] GFP-His铸型 DNA又は GST- His铸型 DNAを固定化した複合糸の模式図を図 4 (b [0120] Figure 4 (b) shows a schematic diagram of a composite thread with immobilized GFP-His 铸 type DNA or GST-His 铸 type DNA.
6 6 6 6
)に示す。この複合糸において、図 4 (b)に示すように、 GFP- His铸型 DNA (スポット 1, ). In this composite yarn, as shown in Fig. 4 (b), GFP-His 铸 DNA (spot 1,
6 6
3,5,7,9)及び GST- His铸型 DNA (スポット 2,4,6,8)は、それぞれ 5及び 4ケ所に交互に 3,5,7,9) and GST-His-type DNA (spots 2,4,6,8) alternately in 5 and 4 locations, respectively.
6 6
スポットされている。この複合糸に固定ィ匕されたタンパク質を抗 His抗体、抗 GFP抗体 Have been spotted. Anti-His antibody, anti-GFP antibody
6 6
及び抗 GST抗体を用いて検出した結果、図 4 (a)に示すように、抗 His抗体で検出し As a result of detection using anti-GST antibody, as shown in Fig. 4 (a), detection was performed using anti-His antibody.
6 6
た場合には 9ケ所のスポット (スポット 1〜9)が確認され、抗 GFP抗体で検出した場合に は一力所おきに 5ケ所のスポット (スポット 1,3,5,7,9)が確認され、抗 GST抗体で検出し た場合には一力所おきに 4ケ所のスポット (スポット 2,4,6,8)が確認された。また各シグ ナルが独立して検出されていることから、各スポット間でのタンパク質のコンタミネーシ ヨンは無 、又は非常に低 、ことが予測された。 9 spots (spots 1-9) were confirmed, and 5 spots (spots 1, 3, 5, 7, 9) were confirmed every other spot when detected with anti-GFP antibody. When detected with anti-GST antibody, four spots (spots 2, 4, 6, 8) were confirmed every other place. Moreover, since each signal was detected independently, it was predicted that there was no or very low protein contamination between spots.
[0121] 綿糸に固定ィ匕されたタンパク質を、 Cy5標識抗ゥサギ IgG(H+L)抗体及び AF488標 識抗ネズミ IgG(H+L)抗体を用いて検出した結果、図 5 (a)及び (b)に示すように、 GFP -His及び GST- Hisの両タンパク質を同時に検出できることが確認された。すなわち[0121] As a result of detecting the protein immobilized on the cotton thread using the Cy5-labeled anti-rabbit IgG (H + L) antibody and the AF488-labeled anti-murine IgG (H + L) antibody, FIG. 5 (a) and As shown in (b), it was confirmed that both GFP-His and GST-His proteins could be detected simultaneously. Ie
6 6 6 6
、複合糸に固定されたタンパク質の検出系のマルチプレックス化が可能であることが 確認された。 It was confirmed that the detection system of the protein fixed to the composite yarn can be multiplexed.
[0122] 〔実施例 2〕 [Example 22]
実施例 2は、ニッケルキレート及び铸型 DNAが固定ィ匕された一本の綿糸を in vitro 転写 ·翻訳系に供し、铸型 DNAから発現した Hisタグ標識タンパク質を綿糸上に固定 Example 2 uses an in vitro transcription / translation system with a single cotton thread in which nickel chelate and cage DNA are immobilized, and the His-tagged protein expressed from the cage DNA is immobilized on the cotton thread.
6 6
化した実施例である。 This is an example.
[0123] 1.ニッケルキレート及び铸型 DNA固定ィ匕綿糸の作製 [0123] 1. Preparation of nickel chelate and cocoon-type DNA-fixed cotton yarn
綿糸の活性ィ匕は実施例 1と同様に行い、キレートイ匕及び抗体のカップリングは以下 のように行った。 The cotton yarn activity was carried out in the same manner as in Example 1, and the chelate yarn and antibody coupling were carried out as follows.
[0124] (1)キレートイ匕及び抗体のカップリング [0124] (1) Chelating chelate and antibody coupling
活性ィ匕した糸を 3本用意し、蒸留水 3mlで 3回洗浄 (4°C)した後、 10mg/mlの AB-NTA /0.1Mリン酸緩衝液 (pH 7.5)を lmlカ卩え、室温で 24時間反応させた。 0.1Mリン酸緩衝 液 (pH 7.5) 3mlで 3回洗浄した後、 10mgの抗ジゴキシゲニン (DIG)抗体を含む 0.1Mリ ン酸緩衝液 (pH 7.5)を 100 1カ卩え、室温で 24時間反応させた。 0.1Mリン酸緩衝液 (p H 7.5) 3mlで 3回洗浄した後、 0.1Mモノエタノールァミン (pH 7.5) 50mlを加え、室温 で 24時間反応させた。 0.1Mリン酸緩衝液 (pH 7.5) 3mlで 3回洗浄した後、 0.1Mモノ エタノールァミン (pH 7.5) 50mlをカ卩え、室温で 24時間反応させた。 0.1 Mリン酸緩衝 液 (pH 7.5) 3mlで 3回洗浄した後、 1%酢酸ニッケル水溶液に室温で 2時間浸漬し、蒸 留水 3mlで 3回洗浄した。 Prepare three activated yarns, wash them with 3 ml of distilled water 3 times (4 ° C), and then add 10 ml of AB-NTA / 0.1M phosphate buffer (pH 7.5) The reaction was allowed to proceed for 24 hours at room temperature. 0.1M phosphate buffer (pH 7.5) Wash 3 times with 3 ml, and then add 100 ml of 0.1M phosphate buffer (pH 7.5) containing 10 mg of anti-digoxigenin (DIG) antibody for 24 hours at room temperature. Reacted. 0.1M phosphate buffer (p After washing 3 times with 3 ml of H 7.5), 50 ml of 0.1M monoethanolamine (pH 7.5) was added and allowed to react at room temperature for 24 hours. After washing 3 times with 3 ml of 0.1 M phosphate buffer (pH 7.5), 50 ml of 0.1 M monoethanolamine (pH 7.5) was added and reacted at room temperature for 24 hours. The plate was washed 3 times with 3 ml of 0.1 M phosphate buffer (pH 7.5), then immersed in a 1% aqueous nickel acetate solution at room temperature for 2 hours, and washed 3 times with 3 ml of distilled water.
以上のようにして、抗 DIG抗体及びニッケルキレートが表面に固定された綿糸を作 製した。 As described above, a cotton thread having an anti-DIG antibody and nickel chelate immobilized on the surface was produced.
[0125] (2)綿糸への铸型 DNAの固定ィ匕 [0125] (2) Fixation of cocoon-shaped DNA to cotton thread
抗 DIG抗体及びニッケルキレートが表面に固定された綿糸に 6-10mm間隔にて 10% Block ace, 10% Ficollを 0.2 μ 1スポットし、室温で 30分間乾燥させた。 Block ace, Ficoll をスポットした間に DIG標識铸型 DNAを 0.2 1スポットした後、室温で 30分間乾燥させ 、 PBSで洗浄し、 10mM Tris- HCl(pH7.5)で洗浄した。なお、 DIG標識铸型 DNAをスポ ットすると、各铸型 DNA溶液は綿糸にしみ込み、铸型 DNA溶液間のコンタミネーショ ンが生じるおそれがあるが、 Block ace, Ficollをスポットした間に DIG標識铸型 DNAを スポットすることにより、各铸型 DNA溶液のコンタミネーシヨンは防止される。 10% Block ace, 10% Ficoll was spotted on a cotton thread with anti-DIG antibody and nickel chelate immobilized on the surface at intervals of 6-10 mm and dried at room temperature for 30 minutes. After spotting 0.21 of DIG-labeled vertical DNA while spotting Blockace and Ficoll, it was dried at room temperature for 30 minutes, washed with PBS, and washed with 10 mM Tris-HCl (pH 7.5). When spotted with DIG-labeled saddle DNA, each saddle DNA solution may permeate into the cotton thread and cause contamination between the saddle DNA solutions. However, while spotting Block ace and Ficoll, By spotting DIG-labeled vertical DNA, contamination of each vertical DNA solution is prevented.
[0126] 以上のようにして、ニッケルキレート及び铸型 DNAが固定ィ匕された綿糸を作製した( 図 6 (a)参照)。なお、図 6 (a)は、ニッケルキレート及び铸型 DNAが固定ィ匕された綿 糸の模式図を示す。 [0126] As described above, a cotton yarn in which nickel chelate and cage DNA were immobilized was prepared (see FIG. 6 (a)). FIG. 6 (a) shows a schematic diagram of a cotton thread to which nickel chelate and cage DNA are immobilized.
[0127] 2. in vitro転写'翻訳系によるタンパク質の発現 [0127] 2. In vitro transcription 'protein expression by translation system
ニッケルキレート及び铸型 DNAが固定ィ匕された綿糸を、実施例 1と同様に RTSを用 いた in vitro転写 ·翻訳系により供し、タンパク質を発現させた。反応液はロシュ社の キット付属プロトコルに従って調製し、 37°Cで 2時間反応させた。反応後実施例 1と同 様の方法で、蛍光標識抗体による検出を行った。 The cotton yarn in which the nickel chelate and the cocoon-type DNA were immobilized was used in the in vitro transcription / translation system using RTS in the same manner as in Example 1 to express the protein. The reaction solution was prepared according to the protocol supplied with the Roche kit and reacted at 37 ° C for 2 hours. After the reaction, detection with a fluorescent-labeled antibody was performed in the same manner as in Example 1.
[0128] その結果、図 6 (b)に示すように、同一糸上にニッケルキレート及び铸型 DNAが存 在している状態であっても、铸型 DNA力も発現した GFP-His及び GST-Hisタンパク As a result, as shown in FIG. 6 (b), GFP-His and GST- that also expressed saddle-type DNA force even when nickel chelate and saddle-type DNA existed on the same thread. His protein
6 6 質は糸上に各スポットとして固定ィ匕された。なお、各铸型 DNAの間隔を 6mmまで狭め ても、タンパク質のスポットの識別は可能であった。 6 6 The quality was fixed on the yarn as each spot. In addition, protein spots could be identified even when the distance between each type of DNA was reduced to 6 mm.
[0129] 〔実施例 3〕 実施例 3は、ニッケルキレート及び铸型 DNAが固定ィ匕された一本の綿糸を in vitro 転写 ·翻訳系に供し、铸型 DNAから発現した Hisタグ標識タンパク質を綿糸上に固定 [Example 3] Example 3 uses an in vitro transcription / translation system with a single cotton thread with nickel chelate and anchored DNA immobilized on it, and the His-tagged protein expressed from the anchored DNA is immobilized on the cotton thread.
6 6
化し、綿糸上に固定ィ匕されたタンパク質の各種活性を検出した実施例である。 This is an example in which various activities of the protein immobilized on the cotton yarn were detected.
[0130] 綿糸の活性化、キレートイ匕及び抗体のカップリングは実施例 2と同様に行った。実 施例 3で用いた各铸型 DNAの構造の模式図を図 7に示す。 His -GST铸型 DNA (配列 [0130] Activation of cotton yarn, chelating candy and antibody coupling were carried out in the same manner as in Example 2. Fig. 7 shows a schematic diagram of the structure of each cage DNA used in Example 3. His-GST-type DNA (sequence
6 6
番号 6参照)、 β gal-His铸型 DNA (配列番号 8参照) , β gal(H)- His铸型 DNA (配列 No. 6), β gal-His type DNA (see SEQ ID No. 8), β gal (H)-His type DNA (sequence
6 6 6 6
番号 9参照) , β gal(L)- His铸型 DNA (配列番号 10参照)は、それぞれ、 glutathione s No. 9), β gal (L) -His-type DNA (see SEQ ID No. 10) is glutathione s
6 6
-transferase遺伝子を発現ベクター pIVEX2.4cに、抗 j8 galactosidaseScFv及び抗 j8 ga lactosidaseScFvの H鎖及び L鎖を pIVEX2.3にクロー-ングすることにより作製した。 Hi s -BAP铸型 DNA (配列番号 7参照)は、ロシュ社製の Linear template generation set, The -transferase gene was prepared by cloning the H chain and L chain of anti-j8 galactosidase ScFv and anti-j8 galactosidase ScFv into pIVEX2.4c in pIVEX2.3c. Hi s -BAP-type DNA (see SEQ ID NO: 7) is a Linear template generation set, manufactured by Roche
6 6
His- tagを用いて大腸菌の alkaline phosphataseの N末端側に Hisタグを融合発現す Fusion expression of His tag on the N-terminal side of alkaline phosphatase of Escherichia coli using His-tag
6 6
る様に構築した。綿糸への铸型 DNAの固定化、及び in vitro転写 ·翻訳系によるタン ノ ク質の発現は実施例 2と同様にして行った。 It was constructed as follows. Immobilization of silkworm DNA on cotton yarn and expression of the protein by an in vitro transcription / translation system were carried out in the same manner as in Example 2.
[0131] (l) GSTタンパク質のダルタチオン結合能の検出 [0131] (l) Detection of daltathione binding ability of GST protein
RTS反応後、 PBS洗浄した His -GST铸型 DNA固定糸を 1% block aceでブロッキング After RTS reaction, PBS-washed His-GST-type DNA fixation thread is blocked with 1% block ace
6 6
し、 2 g/mlの POD標識ダルタチオンに 30分浸漬した。 PBS緩衝液で洗浄した後、 EC L Detection Reagentsを 10 μ 1加え、 ARGUS (浜松ホトニタス)にて測定した。 The sample was then immersed in 2 g / ml POD-labeled dartathione for 30 minutes. After washing with PBS buffer, 10 μl of EC L Detection Reagents was added and measurement was performed with ARGUS (Hamamatsu Photonicus).
[0132] (2)アルカリフォスファターゼ活性の検出 [0132] (2) Detection of alkaline phosphatase activity
RTS反応後、 PBS洗浄した His -BAP铸型 DNA固定糸に CDP-star試薬(ロッシュ)を After RTS reaction, add PBS-star reagent (Roche) to His-BAP-type DNA fixation thread washed with PBS
6 6
加え、 ARGUSにて測定した。 In addition, it was measured with ARGUS.
[0133] (3)抗 j8 galactosidase ScFvの抗体活性の検出 [0133] (3) Detection of antibody activity of anti-j8 galactosidase ScFv
RTS反応後、 PBS洗浄した β gal-His及び β gal(H)- His + β gal(L)- His铸型 DNA固 After RTS reaction, PBS washed β gal-His and β gal (H) -His + β gal (L) -His 铸 DNA
6 6 6 6 6 6
定糸を 1% block aceでブロッキングし、 50 μ g/mlの j8 galactosidaseに 30分間浸漬した 。 PBS緩衝液で洗浄した後、 100倍希釈した抗 |8 galactosidase抗体に 30分間浸漬し、 PBS緩衝液で洗浄した。その後、 100倍希釈した POD標識抗ゥサギ IgG抗体に 30分間 浸漬した。 PBS緩衝液で洗浄した後、 ECL Detection Reagentsを 10 μ 1加え、 ARGUS にて測定した。 The fixed yarn was blocked with 1% block ace and immersed in 50 μg / ml j8 galactosidase for 30 minutes. After washing with PBS buffer, it was immersed in 100 times diluted anti | 8 galactosidase antibody for 30 minutes and washed with PBS buffer. Thereafter, the cells were immersed in a 100-fold diluted POD-labeled anti-rabbit IgG antibody for 30 minutes. After washing with PBS buffer, 10 μl of ECL Detection Reagents was added and measured with ARGUS.
[0134] (4)結果 綿糸から発現し、同じ綿糸上に固定ィ匕された His -GSTタンパク質のダルタチオン結 [0134] (4) Results Daltathione binding of His-GST protein expressed from cotton thread and anchored on the same cotton thread
6 6
合能について、 POD-ダルタチオンを用いて結合実験を行った結果、図 8 (a)に示す ように、 His -GSTの铸型 DNAを固定化した位置にのみ POD -ダルタチオン由来の発 As a result of a binding experiment using POD-Daltathion, as shown in Fig. 8 (a), the POD-Daltathion-derived gene was generated only at the position where the His-GST vertical DNA was immobilized.
6 6
光シグナルが検出された。 A light signal was detected.
[0135] 綿糸から発現し、同じ綿糸上に固定ィ匕された His -BAPタンパク質のアルカリフォス [0135] Alkaline phos of His-BAP protein expressed from cotton thread and immobilized on the same cotton thread
6 6
ファターゼ活性について、発光基質を含む CDP-Star試薬を加え、発光シグナルを測 定した結果、図 8 (b)に示すように、 His -BAP铸型 DNA特異的に発光シグナルが観 As for the phatase activity, CDP-Star reagent containing a luminescent substrate was added and the luminescence signal was measured. As a result, as shown in Fig. 8 (b), the luminescence signal was observed specifically for His-BAP-type DNA.
6 6
察された。 BAPタンパク質は二量体として活性を有することから、発現したタンパク質 は糸上でホモ二量体を形成しうることが示唆された。 Was observed. The BAP protein has activity as a dimer, suggesting that the expressed protein can form a homodimer on the thread.
[0136] 綿糸から発現し、同じ綿糸上に固定ィ匕された抗 β galactosidase ScFvの抗体活性に ついて、抗原との特異結合能の検出を試みた結果、図 8 (c)に示すように、抗 j8 galac tosidase ScFvは、 j8 galactosidaseと特異的に結合したのみでなぐ H鎖、 L鎖を個別 の Hisタグ融合遺伝子として構築した铸型 DNAを混合し、スポットした場合でも、糸上[0136] As a result of an attempt to detect the specific binding ability of the anti-β galactosidase ScFv expressed from cotton thread and immobilized on the same cotton thread, as shown in Fig. 8 (c), Anti-j8 galactosidase ScFv is not only bound specifically to j8 galactosidase, but also when mixed with spotted DNA constructed with H- and L-chains as individual His-tag fusion genes,
6 6
でへテロ二量体を形成し、抗体活性を有することが確認された。 In which a heterodimer was formed and was confirmed to have antibody activity.
[0137] 〔実施例 4〕 [Example 4]
実施例 4は、綿糸と同様のセルロースを原料としたセルロース膜 (セロファン)力もな る平面状の担体を用いた場合の、タンパク質の発現及び固定ィ匕について検討を行つ た実施例である。 Example 4 is an example in which protein expression and immobilization were examined in the case of using a planar carrier having cellulose membrane (cellophane) force made of cellulose similar to cotton yarn.
[0138] セルロース膜の活性化、キレートイ匕及び抗体のカップリングは実施例 2と同様に行 つた o [0138] Activation of the cellulose membrane, chelation, and antibody coupling were performed in the same manner as in Example 2.
セルロース膜への铸型の固定及び in vitro転写'翻訳系によるタンパク質の発現は 、 10%Block ace, 10%Ficollのスポットを除き、実施例 2と同様の方法で行った。また、 RTS反応は、膜上に lcm2当たり 25 1の RTS反応液をカ卩え、乾燥を防ぐため表面をパ ラフイルムで被った後、湿度を保った状態で行った。 The anchor-shaped fixation on the cellulose membrane and the expression of the protein by the in vitro transcription / translation system were performed in the same manner as in Example 2 except for the spots of 10% Block ace and 10% Ficoll. In addition, the RTS reaction was carried out in a state in which 25 1 RTS reaction solution per 1 cm 2 was placed on the membrane, the surface was covered with a film to prevent drying, and the humidity was maintained.
セルロース膜に固定ィ匕されたタンパク質の検出は、実施例 2と同様の方法で行った The detection of the protein immobilized on the cellulose membrane was performed in the same manner as in Example 2.
[0139] セルロース膜に GFP-His铸型 DNA及び GST- His铸型 DNAを固定化し、 RTS反応 [0139] Immobilization of GFP-His 铸 type DNA and GST-His 铸 type DNA on cellulose membrane and RTS reaction
6 6 6 6
を行った後、抗体を用いて各タンパク質を検出した結果、図 9 (a)に示すように、セル ロース膜上では GFP-His由来のシグナルは検出されたが、 GST-HisのシグナルはAs shown in Fig. 9 (a), each cell was detected using an antibody. The signal derived from GFP-His was detected on the loin membrane, but the signal of GST-His
6 6 6 6
検出されなかった。また、 RTSの反応温度 (37°C→30°C)を変えた場合、図 9 (b)に示 すように、綿糸ではどちらの温度でも GFPのシグナルが検出された力 セルロース膜 では 37°Cで GFPのシグナルが検出されたものの、 30°Cでは検出されなかった。我々 は、ウェスタンブロッテイング等の解析により GFPは GSTより RTSでの発現効率が高!ヽ ことを確認している力 実施例 1、 2で示したように糸上での発現実験ではこの 2種の 铸型 DNA由来のタンパク質はほとんど同様のシグナル強度で検出されている。このこ とより、セルロース膜より複雑な表面構造を持つ綿糸は、発現したタンパク質を効率よ く固定ィ匕すると予想され、 RTSにおけるタンパク質発現量効率の違いによる影響を受 けにくいことが示唆された。 Not detected. In addition, when the RTS reaction temperature (37 ° C → 30 ° C) was changed, as shown in Fig. 9 (b), the force at which the GFP signal was detected at either temperature in the cotton yarn was 37 ° in the cellulose membrane. Although a GFP signal was detected in C, it was not detected at 30 ° C. We have confirmed that GFP has higher RTS expression efficiency than GST by analysis such as Western blotting etc. As shown in Examples 1 and 2, these two types of expression experiments on yarn The 铸 -type DNA-derived protein is detected with almost the same signal intensity. This suggests that the cotton yarn with a more complex surface structure than the cellulose membrane is expected to fix the expressed protein efficiently and is less susceptible to the difference in protein expression efficiency in RTS. .
Claims
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006546776A JPWO2006062200A1 (en) | 2004-12-09 | 2005-12-09 | Nucleic acid library and protein library |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004-357467 | 2004-12-09 | ||
| JP2004357467 | 2004-12-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2006062200A1 true WO2006062200A1 (en) | 2006-06-15 |
Family
ID=36578020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2005/022688 Ceased WO2006062200A1 (en) | 2004-12-09 | 2005-12-09 | Nucleic acid library and protein library |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2006062200A1 (en) |
| WO (1) | WO2006062200A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008130053A1 (en) * | 2007-04-23 | 2008-10-30 | Synthera Technologies Co., Ltd. | Fused protein comprising protein g with avidin |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002253240A (en) * | 2001-02-27 | 2002-09-10 | Gencom Co | Analysis of intermolecular interaction |
| WO2003083111A1 (en) * | 2002-03-29 | 2003-10-09 | Precision System Science Co.,Ltd. | Nucleic acid library and protein library |
| JP2004536565A (en) * | 2001-01-23 | 2004-12-09 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | Nucleic acid programmed protein array |
-
2005
- 2005-12-09 JP JP2006546776A patent/JPWO2006062200A1/en active Pending
- 2005-12-09 WO PCT/JP2005/022688 patent/WO2006062200A1/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004536565A (en) * | 2001-01-23 | 2004-12-09 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | Nucleic acid programmed protein array |
| JP2002253240A (en) * | 2001-02-27 | 2002-09-10 | Gencom Co | Analysis of intermolecular interaction |
| WO2003083111A1 (en) * | 2002-03-29 | 2003-10-09 | Precision System Science Co.,Ltd. | Nucleic acid library and protein library |
Non-Patent Citations (2)
| Title |
|---|
| HAGIWARA T. ET A.: "Protein Strand: Array-ka Tanpakushitsu ni yoru Kino Kaiseki to Jidoka no Kento", ANNUAL MEETING OF THE MOLECULAR BIOLOGY SCIENTY OF JAPAN KOEN YOSHISHU, vol. 28TH, 25 November 2005 (2005-11-25), pages 547, 2P-1193, XP003007377 * |
| HAGIWARA T. ET AL.: "Musaibo Tensha Hon'yakukei o Mochiita Protein Array Ito no Sakusei", ANNUAL MEETING OF THE MOLECULAR BIOLOGY SCIENTY OF JAPAN PROGRAM.KOEN YOSHISHU, vol. 27TH, 25 November 2004 (2004-11-25), pages 876, 3PA-323, XP003007376 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008130053A1 (en) * | 2007-04-23 | 2008-10-30 | Synthera Technologies Co., Ltd. | Fused protein comprising protein g with avidin |
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2006062200A1 (en) | 2008-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7883848B2 (en) | Regulation analysis by cis reactivity, RACR | |
| US20200370095A1 (en) | Spatial Analysis | |
| Kukar et al. | Protein microarrays to detect protein–protein interactions using red and green fluorescent proteins | |
| CN116829733A (en) | Compositions and methods for binding analytes to capture probes | |
| JP4959691B2 (en) | Repeatable protein arrays | |
| US7794946B1 (en) | Microarray and uses therefor | |
| EP1737982A2 (en) | Nucleic-acid programmable protein arrays | |
| JP2003004738A (en) | Microarray and its manufacturing method | |
| US7125669B2 (en) | Solid-phase immobilization of proteins and peptides | |
| US20080214408A1 (en) | In situ assembly of protein microarrays | |
| US20180217140A1 (en) | Lateral flow device | |
| US20080269069A1 (en) | Method of Performing a Microarray Assay | |
| WO2006062200A1 (en) | Nucleic acid library and protein library | |
| US20040197779A1 (en) | Methods for analyzing mixtures of proteins | |
| JP2009162769A (en) | Methods and compositions for determining purity of chemically synthesized nucleic acid and purifying chemically synthesized nucleic acid | |
| Liao et al. | Novel probes for protein chip applications | |
| CN121039293A (en) | Compositions and methods for molecular barcoding | |
| JP4437193B2 (en) | Nucleic acid library and protein library | |
| JP6076500B2 (en) | Target substance detection method | |
| WO2008140538A1 (en) | Dna display screen for expression product with desired binding properties | |
| WO2005001086A1 (en) | IMMOBILIZED mRNA-PUROMYCIN CONJUGATE AND USE THEREOF | |
| CA2374438A1 (en) | Detection system for studying molecular interactions and its preparationand use | |
| JP2005504309A5 (en) | ||
| US20030049694A1 (en) | Production of fusion proteins and use for identifying binding molecules | |
| WO2003018773A2 (en) | In vitro protein translation microarray device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2006546776 Country of ref document: JP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 05814280 Country of ref document: EP Kind code of ref document: A1 |